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Abstract 
Sluggish cognitive tempo (SCT) is a recently identified mental health construct. 
Currently, no widely accepted diagnostic criteria for SCT exist, and it is not recognized in 
the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.; DSM-5). There is debate in the psychological community as to 
whether SCT is better conceptualized as an atypical presentation of attention-
deficit/hyperactivity disorder (ADHD) or a unique symptom cluster comprised of ADHD 
and additional psychological and neurocognitive symptoms. When controlling for ADHD 
symptomatology, SCT has been found to be associated with internalizing symptoms, such 
as anxiety and depression, as well as impaired cognitive functioning, such as deficits in 
executive function and slow processing speed. The current study examined groups of 
adults diagnosed with varying levels of ADHD and SCT symptomatology to determine 
whether they differed in their internalizing symptoms and cognitive functioning. 
Analyses indicated subjects with clinical levels of both ADHD and SCT had higher 
scores on measures of internalizing symptoms and executive dysfunction than those with 
ADHD and subclinical symptoms of SCT or those with ADHD only. Regression analyses 
identified symptoms of depression and executive dysfunction that significantly predicted 
subjects SCT symptoms. It is hoped the current study will inform the assessment and 
treatment of adults with ADHD, SCT, and internalizing symptoms.  
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Chapter 1: Introduction 
Statement of the Problem 
The American Psychiatric Association’s (2013) Diagnostic and Statistical 
Manual of Mental Disorders (5th ed.; DSM-5) defines attention-deficit/hyperactivity 
disorder (ADHD) as a neurodevelopmental disorder that results in difficulty sustaining 
attention, hyperactivity, and/or impulsive behavior that interferes with social, academic, 
or occupational functioning (American Psychiatric Association, 2013). Sluggish 
cognitive tempo (SCT) is a conceptualized as constellation of psychological symptoms 
characterized by feelings of apathy and lethargy, difficulty concentrating, daydreaming, 
and slowed cognition that negatively impacts mental health functioning (Becker & 
Barkley, 2018). Initially hypothesized as a potential subset of ADHD symptomatology, 
recent research has concluded that SCT is distinct from ADHD, and other mental health 
disorders (Barkley, 2012, 2014; Becker, Marshall, & McBurnett, 2014). Although SCT is 
recognized, by some, as a separate disorder from ADHD, approximately half of all adults 
with clinically elevated symptoms of SCT have a co-occurring ADHD diagnosis 
(Barkley, 2012). 
A literature review of PsychINFO, Google Scholar, and Ebscohost revealed a 
number of studies exploring how children and adults with ADHD and SCT differ in the 
types of difficulties they experience. The most relevant are cited below. Studies of these 
differences in children and adults found unique associations of SCT with internalizing 
symptoms, lower academic performance, lower annual income, impaired organization 
and problem solving skills, increased stress, and poorer quality of life, even when 
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controlling for the influence of more widely-accepted ADHD symptoms (Becker et al., 
2018; Becker, Marshall, & McBurnett, 2014; Barkley, 2012; Combs et al., 2014, 2015).  
Although SCT and ADHD are theorized to be distinct from one another, their 
close relationship, along with SCT’s status as a newly identified and less well-defined 
mental health construct makes SCT difficult to examine. At this point, it is unclear 
whether SCT is a transdiagnostic factor present in many psychopathologies or is better 
conceptualized as a distinct mental health issue or diagnosis (Lunsford-Avery & Mitchell, 
2018). Few studies have examined both ADHD and SCT’s close relationship with 
internalizing symptoms and various types of comorbid dysfunction or impairment 
associated with these disorders in adult populations (Becker & Barkley, 2018).  
Purpose of the Study  
ADHD and SCT are two related but distinct psychological syndromes that are 
both associated with impairment in social-emotional, academic, vocational, and executive 
functioning (Becker & Barkley, 2018). SCT is still a relatively new psychological 
construct that is poorly understood, due to the both complexity of the phenomenon and 
limited research. At this point, it there is debate about whether SCT should be 
conceptualized as a transdiagnostic factor present in many psychopathologies or as a 
distinct mental health issue, which is more or less related to ADHD (Lunsford-Avery & 
Mitchell, 2018). A small but growing number of studies have examined both ADHD and 
SCT’s close relationship with internalizing symptoms and differences in the types of 
comorbid impairment associated with these disorders in adult populations (Becker & 
Barkley, 2018). This study examined how comorbid issues present in adults with varying 
levels of SCT and ADHD. Specifically, this study sought to learn what, if any, 
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differences exist between these groups in their internalizing symptoms and cognitive 
functioning. 
SCT and ADHD are distinct mental health constructs, with evidence for 
comorbidity. By examining the differences in internalizing symptoms and cognitive 
functioning in adults with varying levels of ADHD and SCT, it is hoped that this study 
will better inform assessment and treatment planning for these often complex and 
challenging cases. Gaining knowledge of these differences may improve clinicians’ 
capacity to differentiate between SCT and ADHD during their diagnostic process as well 
as offer potential targets for treatment the clinician and client may not have initially 
considered.  
Consequently, this study compared subjects who meet criteria for adult ADHD 
and SCT (ADHD + SCT), with subjects who meet criteria for ADHD with subclinical 
levels of SCT (ADHD + subclinical SCT), subjects who only meet criteria for ADHD 
(ADHD only), and subjects who only meet criteria for SCT (SCT only). These diagnostic 
groups were compared on measures of internalizing symptoms and cognitive functioning. 
In this way, the four groups could be compared to determine if there were significantly 
different levels of internalizing symptoms and cognitive functioning. Furthermore, this 
study analyzed subjects’ data to identify which variables are the best predictors of SCT 
symptomatology.  
Hypotheses 
Hypothesis 1. There would be a significant difference between subjects 
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD only, and SCT only, 
with those diagnosed with ADHD + SCT having higher levels of internalizing symptoms 
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than the other groups. For hypothesis 1 and hypothesis 2, ADHD was operationally 
defined as meeting DSM-5 criteria for ADHD-In, ADHD-H/I, or ADHD-C as determined 
by clinician ratings from the Structured Clinical Interview for DSM-5 Disorders (SCID-
5). SCT was operationally defined as a score of 93rd percentile or higher for the subjects’ 
reference age group on the BAARS-IV SCT subscale (the threshold for clinically 
significant levels of SCT outlined in the BAARS-IV manual). Subjects whose SCT 
scores are in the Borderline range as outlined in the BAARS-IV manual (85th to 92nd 
percentile) do not meet criteria for SCT while still having notable levels SCT 
symptomatology. Their borderline impaired scores do not allow SCT to be easily 
classified as present or absent. This presentation of SCT is referred to as “subclinical 
SCT” for comprehension’s sake. Subjects were considered to not meet criteria for SCT if 
their scores on the BAARS-IV SCT subscale were at the 84th Percentile or lower 
(reflecting nonsignificant or marginal levels of SCT as outlined in the BAARS-IV 
manual). Internalizing symptoms were operationally defined as scores on the BDI-II, 
Penn State Worry Questionnaire (PSWQ), the affect subscale of the Brown Attention 
Deficit Disorder Scale-Adult Version (BADDS), and Neuroticism scale of the NEO-PI-R. 
Hypothesis 2. There would be a significant difference between subjects 
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD only, and SCT only, 
with those diagnosed with ADHD + SCT exhibiting significantly more impaired 
cognitive functioning than all other groups. Cognitive functioning was operationally 
defined as subjects’ performance on the Coding task and Digit Span task of the WAIS-
IV, and total executive functioning summary score of the BDEFS.  
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Hypothesis 3. Anxiety and deficits in executive functioning will predict the level 
of SCT after accounting for ADHD symptomatology. SCT was operationally defined as 
subjects’ percentile rank on the BAARS-IV SCT subscale (with 93rd percentile and above 
representing clinically significant levels of SCT). Anxiety was operationally defined as 
subjects’ scores on the PSWQ. Executive functioning was operationalized as subjects’ 
total executive functioning summary score of the BDEFS. ADHD symptomatology was 
operationally defined as subjects’ scores on the DSM-IV Inattentive symptoms and DSM-
IV Hyperactive/Impulsive symptoms scales of the CAARS.  
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Chapter 2: Review of the Literature 
Attention-Deficit/Hyperactivity Disorder in Adults  
ADHD is typically thought of as a disorder of childhood, but the identification of 
a 4.4% prevalence of the disorder in adults has been gaining increasing attention among 
clinicians and researchers in recent years (Kessler et al., 2006). The DSM-5 uses two 
symptom dimensions, inattention and hyperactivity/impulsivity, to identify three 
recognized subtypes of ADHD: predominantly inattentive type (ADHD-In), 
predominantly hyperactive-impulsive type (ADHD-H/I), and the combined type (ADHD-
C) (American Psychiatric Association, 2013). The combined subtype is the most common 
in adults, with approximately 62% of adults exhibiting ADHD-C, 31% exhibiting 
ADHD-In, and 7% exhibiting ADHD-H/I. The prevalence of ADHD-C and ADHD-In in 
adults indicates that upwards of 90% of those with adult ADHD exhibit clinically 
significant levels of inattentive symptoms (Wilens et al., 2009). These rates indicate that 
the majority of adults diagnosed with ADHD experience symptoms from the inattentive 
domain of ADHD. Several symptoms of ADHD in adults are nonspecific and can stem 
from other forms of neurological impairment or difficulties caused by another mental 
health issue. 
ADHD is highly comorbid with many other mental health disorders, including 
anxiety disorders, mood disorders, substance use disorders, and intermittent explosive 
disorder (Kessler, et al., 2006). Individuals with adult ADHD have a higher lifetime 
comorbidity rate of internalizing disorders and externalizing disorders compared to the 
general population. These include internalizing disorders such as depressive disorders, 
anxiety disorders, and cluster C personality disorders; as well as externalizing disorders 
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such as Cluster B personality disorders, conduct disorder, and oppositional defiant 
disorder (Jacob et al., 2014). High levels of effortful control and low stress levels are 
protective factors against internalizing disorders (Gulley et al., 2017). 
Models of Attention and Executive Functioning.  
Deficits in attention and self-control (a lack of inhibition) are central to ADHD 
symptomatology. Many models of attention and self-control attribute the symptoms of 
ADHD and SCT to a deficiency or failure of neuropsychological processes. This failure 
has a downstream effect on the capacity to self-regulate behavior. 
An earlier model of ADHD, the self-regulation model, posited by Russell Barkley 
(1997) conceptualizes ADHD as the expression of severely impaired inhibition. In his 
model Barkley defines inhibition as “performance on cognitive and behavioral tasks that 
require withholding of responding, delayed responding, cessation of ongoing responses, 
and resisting distraction or disruption by competing events” (Barkley, 1997, p. 68). When 
the cognitive processes that control inhibition are impaired or dysregulated, cognition 
becomes overburdened by an unfiltered stream of stimuli and individuals are less capable 
of self-regulating responses to said stimuli. Deficits in inhibition lead to thoughts and 
behaviors being influenced more by immediate rewards than by long-term goals or 
executive functioning (Barkley, 1997). The degree to which one is capable of resisting 
stimuli irrelevant to their current goal is defined as persistence. The weaker or more 
dysfunctional the executive functions that control inhibition, the less persistent one is in 
tasks, resulting in the hyperactive/impulsive and inattentive behavior characteristics of 
ADHD (Barkley, 1997; Ducey, 2016).  
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 Barkley’s more recent self-regulation model belongs to the executive function 
theory of ADHD. Broadly speaking, executive functioning is a set of top-down mental 
abilities that requires the collaboration of different cognitive and neuropsychological 
processes. These processes work together to help an individual monitor and regulate 
one’s own behavior over time towards the achievement of a goal or to solve a novel 
problem. When a person’s mental abilities are insufficient to adequately monitor and 
regulate one’s own behavior and as a result, the individual is having difficulty attaining a 
goal or solving a novel problem, they are said to be experiencing executive dysfunction. 
Multiple researchers have proposed that deficits in a specific executive function or broad 
deficits in executive functioning are the source of the inattentive, hyperactive, and 
impulsive symptoms of ADHD (Willcutt et al., 2005). Research consistently finds 
significant relationships and moderate effect sizes in executive functioning deficits and 
ADHD symptomatology. The most consistent executive functioning deficits related to 
ADHD are in inhibition, vigilance/sustained attention, working memory, and planning 
(Willcutt et al., 2005). 
 Another model of attention difficulties in a variety of disorders is Posner’s model 
of attention. Posner’s model posits that separate neurocognitive systems are in charge of 
alerting responses to the appearance of new stimuli; orienting to said stimuli; and 
executive control of thoughts, actions, and emotions in response to these stimuli (Becker 
& Willcutt, 2018). Some have theorized that deficiencies in the orienting system may be 
the cause of SCT symptomatology whereas ADHD symptoms represent deficiencies in 
all three systems (Barkley, 2016; Becker & Willcutt, 2018).  
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Sluggish Cognitive Tempo 
Validating SCT.  
In the 1980s, the delineation between the two symptom dimensions of ADHD 
(then known as Attention Deficit Disorder; APA, 1987) was codified into the third 
edition of the Diagnostic and Statistical Manual of Mental Disorders. This change was 
made to account for children who presented with inattentive but not hyperactive 
symptoms of ADHD. Following the release of the DSM-III, researchers set out to 
examine the differences between these two symptom domains.  
The first of several factor analytic studies examining the symptoms and related 
behaviors of children with ADHD examined the factors that emerged from behavior 
rating scales of children with ADHD (Neeper & Lahey, 1986). They found that a three-
factor model provided the best fit for ADHD. In addition to the expected inattentive and 
hyperactive factors, a “slow tempo” factor emerged. Across multiple studies of ADHD 
symptoms and related behaviors in children, these three factors: hyperactivity–
impulsivity, inattention–disorganization, and “slow tempo” have emerged (Bauermeister 
et al., 2012; Becker, Marshall, & McBurnett, 2014). As research progressed, researchers 
grouped the constellation of symptoms and behaviors related to the slow tempo factor 
under the label sluggish cognitive tempo (SCT).  
The SCT factor consisted of items that captured behaviors described as sluggish, 
apathetic, lethargic, drowsy, and being “in a world of his or her own.” Another factor 
analytic study found 13 features that showed good factor loadings with SCT. This 
included sluggishness, being tired or lethargic, slow thinking/processing, loses train of 
thoughts easily, sleepy or drowsy, spacey, daydreaming, being “in a fog,” being 
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underactive or slow moving, getting lost in thought, staring blankly into space, easily 
confused, and being apathetic or unmotivated. Further studies showed that SCT 
symptoms were uniquely elevated in children with ADHD-In compared to ADHD-H/I. 
(Becker, Marshall, & McBurnett, 2014). Studies of children from general population and 
clinical samples identified the presence of SCT in children without clinical levels of 
ADHD symptomatology and found SCT symptoms to be associated with inattentive 
symptoms (Garner et al., 2010; Wåhlstedt & Bohlin, 2010). 
 In 1987, changes in the revised edition of the DSM-III eliminated the new 
practice of diagnosing ADHD subtypes (APA, 1987). This had the inadvertent effect of 
exiling SCT from entering the official nosology used to diagnose ADHD (Becker, 
Marshall, & McBurnett, 2014). In spite of increased research interest in this third 
dimension of ADHD and evidence that SCT represented a distinct and important domain 
of attentional problems in those with ADHD, SCT remains unincorporated into the 
official nosology of ADHD to this day (Becker, Marshall, & McBurnett, 2014). The 
current conceptualization of SCT describes it as a set of symptoms characterized by 
feelings of apathy and lethargy, difficulty concentrating, and slow cognitive processing 
speed, with strong relationships to established ADHD symptom dimensions (Becker & 
Barkley, 2018).  
As clinical and research interest in adult ADHD grew, interest in whether SCT 
presented in adults followed close behind. Several comprehensive studies were conducted 
by Dr. Russell Barkley as part of the development of the fourth edition of the Barkley 
Adult ADHD Ratings Scale (BAARS-IV). The BAARS-IV is a self- and other-report 
instrument designed to measure the inattentive, hyperactive, and impulsive symptoms of 
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ADHD in adults ages 18-89. For the fourth edition, -nine items used in prior studies of 
SCT in children were added to the BAARS-IV measure. These SCT items and other 
items on the BAARS-IV used to assess for ADHD symptomatology in adults were 
administered to a normative sample of the general population consisting of 1,249 adults 
in the United States. Barkley proposed that an individual must score higher than the 93rd 
percentile of the adults in the sample within the same age bracket on the SCT subscale of 
the BAARS-IV before they are considered to have clinically significant levels of SCT 
(Barkley, 2011a). The SCT subscale measures chronic daydreaming, hypoactivity, mental 
“fogginess,” and difficulty sustaining concentration and alertness during boring tasks. 
Later studies by Barkley used the same normative sample of the general 
population in the Unites States to conduct multiple factor analyses examining differences 
between adults whose SCT scores were in the 95th percentile or higher of the normative 
sample with those whose ADHD scores were in the 95th percentile or higher. This 
research confirmed that the chronic daydreaming, hypoactivity, mental fogginess, and 
tendency to become bored easily, characteristic of SCT, aligns with a different factor than 
the hyperactive-impulsive and inattentive dimensions of ADHD (Barkley, 2011a).  
Barkley determined that, of the participants who met the criteria for clinical levels 
of SCT, 54% also met the criteria for a diagnosis of ADHD. Similarly, 46% of those 
diagnosed with ADHD also met criteria for clinical levels of SCT. This overlap between 
the two disorders is attributed to participants with SCT and/or ADHD both sharing high 
levels of inattentive symptoms (Barkley, 2012). SCT symptoms shared as much as 50% 
of their variance with inattentive symptoms but less than 25% of the variance with 
hyperactive/impulsive symptoms. Furthermore, SCT scores were associated with 
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impairment in social, academic, and emotional functioning, even after controlling for 
comorbid ADHD symptomatology (Becker & Barkley, 2018). Based on these findings, 
Barkley concluded elevated SCT symptoms likely reflect a separate disorder from ADHD 
that is comorbid in approximately half of adults with ADHD (Barkley, 2012). 
Another study set out to examine the reliability and validity of SCT measures in 
an applied clinical setting. Lunsford-Avery et al. (2018) examined client data from a 
medical center’s outpatient specialty clinic for ADHD. This data was collected as part of 
the initial psychological evaluations of new clients presenting for services at the program. 
They found the SCT subscale on the BAARS-IV to be reliable and valid for use in this 
outpatient clinical setting.  
Exploratory factor analysis also found the SCT items of the BAARS-IV clustered 
into three factors: sleepy/sluggish, low initiation/persistence, and slow/daydreamy. The 
low initiation/persistence and slow/daydreamy factors were significantly correlated with 
both inattentive and hyperactive/impulsive symptoms of ADHD. The sleepy/sluggish 
factor was positively associated with inattention but not hyperactivity/impulsivity 
(Lunsford-Avery et al., 2018).  
Empirical studies with large samples of adults and children in a variety of settings 
have demonstrated that SCT is a distinct psychological construct, which is comorbid in 
approximately half of adults with ADHD, particularly so in inattentive presentations 
(Barkley, 2011a, 2012; Becker et al., 2016; Garner et al., 2010; Wåhlstedt & Bohlin, 
2010). The development and application of measures for SCT have made it possible to 
measure SCT in research participants, clinical samples, and the general population 
(Barkley, 2011a, 2012; Lunsford-Avery et al., 2018). Researchers are able to examine the 
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subtle differences in how SCT and ADHD relate to each other, in addition to other mental 
health disorders.  
Depletion Models and SCT.  
The resource model of control posits that the ability to -control one’s behavior 
including thoughts, emotions, and actions relies on limited resources that are depleted as 
an individual exercises self-control. This model defines self-control as a “resource” of 
ability or that allows an individual to attain personal goals by choosing larger but delayed 
long-term rewards over smaller but immediate sources of gratification. As this resource is 
depleted, it becomes more and more difficult for the individual to monitor and self-
control their behavior, resulting in a state referred to as “ego-depletion” (Baumeister, 
2002). Whereas the original theory posited that blood glucose might be the resource 
depleted by this process, later research demonstrated this was not the case (Gailliot et al., 
2007; Inzlicht & Schmeichel, 2012).  
Inzlicht and Schmeichel proposed a revised version of the resource model. Their 
process model of depletion argues that exerting self-control influences motivation and 
attention, which increases the likelihood of a failure in self-control. As mental effort is 
exerted to maintain self-control, motivation begins to shift away from the goal or reason 
for expending effort to maintain self-control (e.g., motivated to maintain a diet) and 
towards a more immediate source of gratification (e.g., motivated to eat ice cream). This 
shift in motivation is coupled with a shift in attention. As one exerts effort to maintain 
self-control, attention shifts away from stimuli or information that they need to continue 
to exert self-control (e.g. focusing on how eating ice cream conflicts with a dieting goal) 
and towards potentially rewarding stimuli (e.g. focusing on how delicious ice cream 
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looks). Inzlicht and Schmeichel proposed ways to counteract the ego-depletion effect, 
such as presenting cues to help refocus attention on reasons for self-control and providing 
rewards or incentives for sustaining self-control, which would increase motivation  
A study examining the ego-depletion paradigm in adults with ADHD compared 
participants with a history of ADHD and a control group without ADHD on their 
performance on a handgrip stamina task and computerized gambling task following a 
continuous performance task. Continuous performance tasks require prolonged, sustained 
attention and are notoriously frustrating and boring. They are thought to be a good way to 
induce ego depletion and measure sustained attention in a laboratory setting. The 
handgrip stamina task and computerized gambling task were used to operationalize self-
control for this study (Lubusko, 2005).  
The continuous performance task was administered to both groups to cause ego-
depletion. Participants’ performance on the gambling task and handgrip task were then 
measured and compared. Results indicated no differences between the participants with 
ADHD and without ADHD on their performance on the gambling task and handgrip task 
following the continuous performance task. This indicates that there was no observed 
difference between the participants with ADHD and without ADHD in the degree of ego-
depletion they experienced (Lubusko, 2005).  
 Although these findings do not support the idea of more severe ego-depletion in 
adults with ADHD, it is important to consider alternative models of resource depletion 
and limitations to the design of the study. This study was conducted before Inzlicht and 
Schmeichel published their model. Considering these findings in the light of the process 
model of depletion, the participants were first given a task that potentially depleted their 
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attention and motivation, then showed no between groups differences on measures of 
impulsivity, persistence, and decision making. The continuous performance task may 
have decreased participants’ attention and motivation, but changes in attention and 
motivation were not measured in this study. The gambling task was originally designed to 
measure decision-making and impulsivity and the handgrip task was designed to measure 
persistence and physical stamina (Lubusko, 2005). Retrospective consideration of these 
findings indicates that the researchers may have erroneously used measures of 
impulsivity and physical exertion to examine the depletion of self-control.  
Individuals with ADHD struggle to regulate attention, sustain motivation, exhibit 
self-control, and activate other executive functions (American Psychiatric Association, 
2013; Barkley, 2011b; Willcutt et al., 2005). If attention and motivation play a key role in 
sustaining self-control as posited by the process model of depletion, then those with 
ADHD would have a particularly difficult time exhibiting self-control due to their 
impaired attention and motivation processes, not just because of depletion of a general 
self-control resource.  
A study comparing children with ADHD and typically developing children on a 
continuous performance task found modest evidence for this model. A continuous 
performance task was administered to all participants twice: once to cause ego-depletion, 
induced by prolonged sustained attention to boring stimuli, and a second to measure 
performance. Half of the children with ADHD and half of the typically developing 
children were offered token reinforces for good performance on the continuous 
performance task that could be exchanged for a small toy at the end of the experiment 
(Dekkers et al., 2017). 
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The children with ADHD exhibited significantly more omission errors and greater 
reaction time variability, both of which are measures of basic attention and common in 
ADHD (Dekkers et al., 2017), than the control group on the initial continuous 
performance task. The ADHD and control groups did not differ significantly on measures 
of inhibition or reaction time (measures of self-regulation) on the initial task. Children 
with ADHD and typically developing children who were offered reinforcement for their 
performance on the second administration of the task all showed less reaction time 
variability and fewer omission errors than those who were not. Furthermore, participants 
with ADHD who were offered reinforcement performed better than those with ADHD 
who were not given reinforcement for their performance. Reinforcement effects did not 
differ between children with ADHD and typically developing children. One potential 
explanation for the lack of difference in reinforcement effects put forth by the authors is 
the elevated reward threshold in children with ADHD. The inexpensive toy might have 
been an insufficient reward to instill high levels of motivation in children with ADHD, 
but was a sufficient reward to produce moderate levels of motivation found in typically 
developing children (Dekkers et al., 2017).  
The results of this study suggest ego-depletion had an impact on measures of 
basic attention but not self-regulation. This decrease in attention was more prevalent in 
children with ADHD, possibly due to their already impaired capacity to sustain attention. 
The ego-depletion effect on attention was mitigated by increasing motivation through an 
external reward, and this mitigating effect brought the performance of children with 
ADHD to the same level as typically developing children (Dekkers et al., 2017). The 
original resource model of control and the notion of ego-depletion have come under 
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scrutiny due to several conflicting meta-analyses and replication studies (Hagger et al., 
2016; Pollert, 2015). However, these findings suggest that the process model of depletion 
may accurately describe the relationship between sustained effort, motivation, and 
attention in those with impaired executive functioning, including those with ADHD and 
potentially SCT. To date, a literature review reveals no studies specifically examining 
SCT in relation to the resource model of control or process model of depletion. 
Nosology and Transdiagnostic Factors 
The DSM-5 conceptualizes mental health disorders in categorical terms, requiring 
a diagnostic threshold of symptoms and other criteria before diagnostic criteria are met 
for various disorders. The DSM-5 classifies disorders with similar features, etiology, and 
diagnostic criteria into categories of related disorders; for instance, neurodevelopmental 
disorders or psychotic disorders. In the past, disorders in different categories were 
presumed to have independent etiologies and share few features in common (American 
Psychiatric Association, 2013). Whereas this framework makes psychopathology easier 
to diagnose and classify, it is recognized that “the boundaries between many disorder 
‘categories’ are more fluid over the life course . . . and many symptoms assigned to a 
single disorder may occur, at varying levels of severity, in many other disorders,” 
(American Psychiatric Association, 2013, p. 5). Furthermore, individuals with a mental 
health disorder are more likely to present with multiple diagnoses than with a single 
disorder (Kessler et al., 2005). Additionally, those who present with symptoms that are 
subthreshold to the diagnostic criteria of a disorder can still experience clinically 
significant distress and impairment in their lives (Krueger & Eaton, 2015). The high 
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prevalence of comorbidity and overlap of symptomatology in various mental health 
diagnoses indicated that there might be common factors shared between many disorders.  
Internalizing and Externalizing Factors  
According to the theory of transdiagnostic factors (TDFs), many psychological 
disorders with similar features (such as disorders of anxiety and mood) are hypothesized 
to stem from one or two underlying core problems, in this case, internalization and 
externalization of negative affect. When individuals experiences distress or is attempting 
to cope with negative emotion, they can choose to internalize these problems by keeping 
these feelings inside or, otherwise, not acknowledging how they feel. They could also 
externalize their problems and direct these negative feelings away from themselves by 
acting out towards people or objects in their environment. According to this theory, these 
underlying factors express themselves as different disorders depending on each 
individual’s unique characteristics and experiences (Krueger & Eaton, 2015).  
One of the first and most prominent theories of TDFs posited the distinction 
between internalizing and externalizing factors in mental health disorders (Achenbach, 
1966). A factor analytic study of psychopathology in children with a variety of mental 
health disorders identified that their symptoms broadly loaded onto these two factors: 
internalizing and externalizing (Achenbach, 1966). The internalizing factor consisted of 
symptoms and behaviors directed inwards and influence the individual’s internal 
psychological experience, such as anxiety, depressive symptoms, social withdrawal and 
isolation, somatic complaints, and traumatic stress. The externalizing factor consisted of 
symptoms and behaviors directed outwards on the individual’s environment, such as 
disruptive, hyperactive, and aggressive behaviors. (Jacob et al., 2014). Later research has 
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validated the existence of these externalizing and internalizing factors in a variety of 
populations (Krueger & Eaton, 2015).  
Additional TDFs have been proposed representing common factors to a large 
number of psychopathologies, which do not load onto the externalizing or internalizing 
factors. These include, but are not limited to, a thought disorder factor, which is common 
to schizophrenia and other psychotic disorders, and an autism factor, which is unique to 
individuals across the autism spectrum (Krueger & Eaton, 2015). Others contend that 
even these factors could be attributed to internalizing or externalizing factors. Following 
the identification of SCT in the mid-1980s, subsequent research has investigated whether 
SCT is another subtype of ADHD, a distinct mental health disorder, or a TDF that 
contributes to multiple mental health disorders.  
 There is currently no consensus regarding the core constructs or nosology used as 
a comprehensive definition of SCT (Becker et al., 2016). A meta-analysis evaluating the 
validity of SCT as a diagnostic construct identified 18 potential core features of SCT 
across multiple disparate measures used by researchers to measure SCT. Of these 18 core 
features, only 13 showed good factor loadings onto the SCT factor in this meta-analysis, 
and encompassed the cognitive and behavioral features of SCT (Becker et al., 2016). The 
other five domains had insufficient factor loadings or loaded stronger onto other factors 
such as ADHD-In symptoms or depression. The SCT construct demonstrated good 
internal validity and moderate external validity across the studies examined. Moderate 
and significant correlations were found between SCT ratings and nearly all of the other 
psychopathologies examined in this study. However, none of these associations were 
high enough that SCT could be considered a redundant conceptualization of a preexisting 
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psychiatric disorder, supporting the notion that SCT is a separate construct from other 
better established and defined established psychopathologies. However, to date, there is 
still insufficient research on SCT to determine if it is best conceptualized as an 
independent psychiatric disorder or better understood as a syndrome or TDF that is 
present across many pathologies (Becker et al., 2016). 
Internalizing Disorders in Those With SCT and ADHD 
A handful of studies have investigated the relationships between SCT; the 
inattentive, hyperactive, and impulsive presentations of ADHD; and internalizing 
disorders. Symptoms of internalizing disorders include anxiety, depression, social 
withdrawal, isolation, somatic complaints, and traumatic stress. Anxious and depressive 
disorders are two of the most common mental health issues in the population. A national 
survey by the American Medical Association examined the prevalence of mental health 
diagnoses from the DSM-IV in the United States. They found anxiety disorders to be the 
most prevalent class of disorders, with 28.8% of the population sample meeting criteria 
for an anxiety disorder at some point in their life. More specifically, the survey also 
found that the four most prevalent mental health disorders were major depressive disorder 
(16.6% prevalence), alcohol abuse (13.2%), specific phobia (12.5%), and social 
phobia/social anxiety disorder (12.1%) (Kessler, Berglund, Demler, Jin, Merikangas, & 
Walters, 2005).  
Anxiety disorders are characterized by excessive fear and anxiety, leading to 
behavioral disturbances. Fear is the negative emotional response to a real, imminent 
threat to one’s well-being, whereas anxiety is the anticipation of future threat (American 
Psychiatric Association, 2013). Anxious symptoms can occur in response to real threats 
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to an individual, and typically dissipates after the threat is gone. Anxiety is considered 
pathological when it regularly occurs in response to perceived, rather than actual threats 
or is disproportionate to the actual threat posed to the individual. Depressive disorders are 
characterized by sadness, irritability, and feelings of emptiness, that are accompanied by 
somatic and cognitive changes. These depressive symptoms significantly impair 
functioning (American Psychiatric Association, 2013). 
Studies of SCT in adults and children have found it to be significantly associated 
with internalizing symptoms including social withdrawal, somatic complaints, anxious 
symptoms, and depressive symptoms (Bauermeister et al., 2012; Becker, Langberg, et al., 
2014). Studies examining externalizing symptoms have found them to be unassociated or 
negatively associated with SCT when controlling for the influence of ADHD symptoms 
(Becker, Marshall, & McBurnett, 2014; Becker, & Langberg, 2013). These findings 
illustrate that SCT and ADHD each have a unique relationship with internalizing 
symptoms, whereas externalizing symptoms are related to ADHD but not SCT.  
This research has established that both ADHD and SCT are related to anxiety and 
depression. However, the close relationship between ADHD and SCT warranted 
examination as to whether the relationship between anxious and depressive symptoms 
and ADHD could be attributable to SCT or vice versa. An additional layer of difficulty 
comes from the challenge of measuring symptoms of anxiety in those with the 
hyperactive symptoms of ADHD, whose chronic restlessness and higher levels of 
physiological arousal can be mistaken for anxiety (Meyer, Miller, Metzger & Borkovec, 
1990; Ramsay, 2015). Furthermore, individuals with ADHD may underreport their level 
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of impairment on self-report measures due to a lack of self-awareness on their behavior 
(Manor et al., 2012).  
One study examining ADHD, SCT, and internalizing symptoms examined the 
symptom profiles of 2,744 children diagnosed with the Inattentive or Combined subtype 
of ADHD. Their information was collected as part of a larger study examining the 
effectiveness of mental health service delivery across nine predominantly low-income 
school districts in Texas. Children with ADHD-In were sorted into a high SCT or low 
SCT group based on whether they had elevated scores on two items from a teacher rating 
scale examining the SCT symptoms of “daydreams or gets lost in his/her thoughts” and 
“underactive, slow moving, or lacks energy” (Carlson, & Mann, 2002).  
These students were also administered the teacher rating form of the Adjustment 
and Behavior Problems Scales (TRF-ABPS), a standardized measure of various 
childhood behavior problems and functioning rooted in Achenbach’s theory of 
internalizing and externalizing disorders. The TRF-ABPS includes an overall 
internalizing behavior composite score calculated from subscales examining symptoms 
such as acting withdrawn, somatic complaints, anxious/depressed symptoms, and social 
problems. The TRF-ABPS also includes an overall externalizing symptoms composite 
score consisting of subscales examining delinquency and aggressive behavior 
(Achenbach, 1991). 
 Pairwise analyses of variance revealed teachers rated children in the high SCT/In 
group significantly higher on the internalizing subscales of overall internalizing behavior, 
acting withdrawn, and somatic complaints on the TRF than those in the low SCT/In 
group and those in the ADHD-C group. Children in the high SCT/In group were rated 
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significantly lower on the externalizing subscale of aggressive behaviors than those in the 
low SCT/In group and those in the ADHD-C group. Although this study was severely 
limited by failure to control for SCT levels in the ADHD-C group and the use of only two 
items from a teacher rating scale to measure SCT, it is one of the first to demonstrate that 
children with ADHD and SCT can be distinguished from those with only ADHD based 
on co-occurring mental health symptoms (Carlson & Mann, 2002).  
 A series of additional studies examining the relationship between SCT, ADHD, 
anxiety, and depression in adults utilized a nonclinical sample of undergraduate students, 
ranging in age from 17 to 34. Hierarchical linear regression examined SCT’s relationship 
with anxiety and depression and academic adjustment while controlling for demographic 
variables and the inattentive, hyperactive, and impulsive symptoms of ADHD (Becker, 
Langberg, et al., 2014). The Depression Anxiety Stress Scales (DASS-21) were used to 
assess the degree of depression and anxiety participants had experienced in the past week. 
Previous studies of the DASS-21 have demonstrated its internal consistency and 
concurrent validity with other measures of depression and anxiety (Antony, Bieling, Cox, 
Enns, & Swinson, 1998).  
Preliminary correlations were used to identify which demographic variables and 
ADHD symptoms would be appropriate to use as predictors in the analyses. Comparisons 
were made between two regression models. The first model used the age, sex, and the 
inattentive, impulsive, and hyperactive subscales from the BAARS-IV as predictors, and 
a second model that added in the SCT subscale of the BAARS-IV as an additional 
predictor. These models were used to predict scores on measures of anxiety, depression, 
and other measures of academic success (Becker, Langberg, et al., 2014).  
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 Comparisons between the two models’ ability to predict anxiety scores on the 
DASS-21 found that the model which included SCT as a predictor explained 6% more of 
the variance than the model which excluded SCT. Furthermore, adding SCT scores as a 
predictor in step two reduced inattentive symptoms and impulsive symptoms ability to 
predict anxiety to nonsignificance. Comparisons between the two models’ ability to 
predict depression scores on the DASS-21 found the second model including SCT 
explained an additional 8% of the variance compared to the first model. In the first 
model, inattentive and hyperactive symptoms were found to be significant predictors of 
depression. In the second model, only SCT emerged as a significant predictor of 
depressive symptoms. (Becker, Langberg, et al., 2014).  
 Another study in this series tested to see if SCT symptoms would continue to be 
the only significant predictor of depression in a sample of college students, in the same 
age range, who met the criteria for ADHD-In or ADHD-C. The model in step one utilized 
ADHD subtype as a categorical variable, age, and a continuous measure of current 
mental health service use. The second added the SCT subscale of the BAARS-IV. 
Consistent with the first study, the model including SCT explained an additional 8% of 
the variance explained compared to the first model (ΔR2 = .08, ΔF(1, 67) = 7.67, p < .01). 
Age remained a good predictor of depression in both models, but neither ADHD subtype 
nor current mental health treatment usage were significant predictors of depression as 
measured by the DASS-21 in either model (Becker, Langberg, et al., 2014). 
 Another study examined whether there were differences between adults diagnosed 
with ADHD who were taking stimulants to treat their symptoms compared to those with 
adult ADHD who were unmedicated. Separate regressions were run for each group using 
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scores on measures of anxiety and depression, and SCT. Participants’ SCT levels, as 
measured by the BAARS-IV, were correlated with ADHD symptomatology in both 
groups. (Leikauf & Solanto, 2017). The State-Trait Anxiety Inventory (STAI) measured 
participants’ anxiety and the Beck Depression inventory (BDI-II) measured their 
depression. The STAI is a clinical measure examining the extent a participant is 
experiencing anxiety in the moment (state anxiety) and their general tendency to respond 
to stressful situations and events with anxiety (trait anxiety; Spielberger, 1989). The BDI-
II is a widely used self-report measure designed to examine the severity of depression 
within the past two weeks (Beck et al., 1996). A multitude of studies have confirmed the 
reliability and validity of the BDI-II in measuring the severity of depressive 
symptomatology across different cultural groups and clinical populations (APA, 2019). 
The reliability and validity of the STAI as a measure of both state and trait anxiety has 
been verified by its creators (Spielberger et al., 1983; Spielberger, 1989). 
Participants’ scores on trait anxiety and state anxiety on the STAI and their scores 
on the BDI-II were significantly positively correlated with SCT in the unmedicated 
group, but were not significant in the group taking stimulants (Leikauf & Solanto, 2017). 
The executive functioning results of this study are discussed below. Because there were 
no premedication measurements of the participants, anxiety and depression levels, it is 
uncertain whether these findings were due solely to the effect of stimulant use or to 
another difference between the unmedicated group and group using stimulants (Leikauf 
& Solanto, 2017).  
 A recent study of SCT in adults with current ADHD symptomatology sorted 
participants into three groups, based on whether they exhibited minimal, moderate, or 
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severe levels of SCT as measured by the BAARS-IV. Researchers used MANOVAs to 
compare the three groups across their presenting levels of internalizing symptoms, 
anxiety, depression, externalizing symptoms, neurocognitive measures, and ADHD 
related impairment while controlling for the influence of inattentive symptoms and 
biological sex. Internalizing, anxiety, and externalizing symptoms were measured by the 
Achenbach System of Empirically Based Assessments, Adult Self-Report (ASEBA). The 
ASEBA measure is similar to the TRF-ABPS in its use of self-report scales to examine 
symptoms indicative of internalizing, externalizing, or anxious symptomatology rooted in 
Achenbach’s theory of TDFs. Reliability and validity of this measure has been 
established by its authors (Achenbach & Rescorla, 2003). Depressive symptoms were 
measured by the Center for Epidemiological Studies Depression Scale, a self-report 
measure examining symptoms associated with depression experienced within the past 
week (CES-D; Radloff, 1977). Participants in the moderate and severe SCT groups 
exhibited significantly higher scores on the ASEBA scale measuring anxiety and the 
CES-D measuring depression than those in the minimal SCT group (Kamradt et al., 
2018). The neurocognitive findings in this study are detailed below.  
 In summary, the aforementioned studies have demonstrated that levels of SCT are 
positively related to internalizing symptoms such as anxiety and depression. Multiple 
studies have confirmed this relationship in children, older adolescents, and adults when 
controlling for symptoms of ADHD and demographic variables. The SCT subscale of the 
BAARS-IV demonstrated consistent and strong associations across studies with a variety 
of measures used to operationalize anxiety and depression. This pattern of similar 
findings across studies using a variety of measures is evidence of a consistent association 
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between SCT and symptoms of both anxiety and depressive symptoms. Furthermore, the 
results of these studies suggest that the relationship between ADHD and anxiety and 
depression may be partially explained by SCT (Becker, Langberg, et al., 2014). One 
theory on the close relationship between these constructs posits that SCT, anxiety, and 
depression may share several core features such as apathy, rumination/daydreaming, 
inactivity, and decreased effort (Smith & Langberg, 2017).  
Neurological Research on ADHD 
 ADHD is a neurodevelopmental disorder characterized by difficulty sustaining 
attention, hyperactivity, and/or impulsive behavior. These symptoms are commonly 
attributed to structural differences in the brain and dysfunction in the creation and 
distribution of dopamine in the brain (Rubia et al., 2014; Wiers et al., 2018).  
Brain Structure and Function in ADHD 
The majority of brain imaging studies on ADHD has been conducted on children. 
These studies have used magnetic resonance imaging (MRI) and diffusion tensor imaging 
(DTI) to examine abnormalities in the brains of those with ADHD. Structural anomalies 
in the frontal, parietal, striatal, and cerebellar regions of the brain, and the white matter 
networks that connect them are closely associated with ADHD symptomatologyin 
children (Rubia et al., 2014). The few published brain imaging studies of adults with 
ADHD have found moderate structural abnormalities in these same brain regions (Rubia 
et al., 2014). Meta-analyses of imaging studies have concluded that abnormalities in the 
basal ganglia are the most consistently found structural abnormality in the brains of those 
with ADHD (Rubia et al., 2014). The structures that make up the basal ganglia (including 
the caudate nucleus, putamen, globus pallidus, and substantia nigra) contribute to 
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processes such as voluntary motor movement and inhibitory control, the reward system 
and motivation, and dopamine synthesis (Kolb & Whishaw, 2015; Rubia et al., 2014).  
Additional structural abnormalities include reduced grey matter volume in the 
prefrontal cortex of individuals with ADHD compared to typically developing individuals 
of the same age (Rubia et al., 2014). Rather than reflecting a consistent structural 
abnormality, longitudinal research has found that the difference is due to a delay in 
cortical development (Kolb & Whishaw, 2015; Shaw et al., 2007; Rubia et al., 2014). The 
human prefrontal cortex controls cognitive processes that allow the selection of behaviors 
or actions to engage in based on internal, external, and context cues. The prefrontal 
cortex also contributes to our knowledge of our autobiographical experiences and 
personal goals, which is referred to as autonoetic awareness (Kolb & Whishaw, 2015). 
Delayed development in the prefrontal cortex may contribute to the impaired self-
regulation of behavior seen in ADHD due to impaired ability to attend to context cues 
and long-term goals.  
Few studies have attempted to differentiate between subtypes of ADHD or 
between ADHD and SCT using brain-imaging techniques. One such study on ADHD 
compared the performance of school age children with ADHD-In to those with ADHD-C 
on a go/no-go task. Go/No-go tasks measure the ability to inhibit responding via button 
press to a decoy stimulus, which looks similar to a target stimulus to which the 
participant is supposed to respond to. During the go/no go task, functional and structural 
MRIs were taken. Analysis of performance revealed no significant differences between 
the ADHD-In and ADHD-C groups on performance of the go/no-go task itself. All 
participants exhibited activation of the temporoparietal junction and right ventrolateral 
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prefrontal cortex during successful inhibition on the go/no-go task. These areas have been 
found to be involved with detecting external cues for behaviors and signaling for the 
suppression of behavior, respectively (Solanto et al., 2009). Children with ADHD-In 
demonstrated a greater magnitude of activation in temporoparietal junction, despite the 
ADHD-In and ADHD-C groups having nonsignificant differences in performance. These 
findings imply that the brains of those with ADHD-In require greater activation of the 
temporoparietal junction to achieve the same level of performance as those with ADHD-
C (Solanto et al., 2009).  
A similar study compared fMRI scans of typically developing adolescents and 
adolescents with ADHD-In during a response inhibition task. The relationship between 
SCT symptomatology and levels of brain activation in different regions was examined 
using regression analysis. Activation in the superior parietal lobule during the inhibition 
task was negatively correlated with parent ratings of SCT symptoms (Fassbender et al., 
2015). The superior parietal lobule receives sensory input from the eyes and hands, and 
assists the rest of the parietal lobe in integrating sensory information. The authors posit 
that the negative relationship between superior parietal lobule activation during the 
response inhibition task and SCT symptoms may represent impairment in the ability to 
reorient attention to a new stimulus (Fassbender et al., 2015). This theory is consistent 
with Posner’s model of attention, which is discussed later.  
The Dopaminergic System 
Dopamine is an amine that functions as both a hormone and neurotransmitter in 
the human body. Nuclei in the substantia nigra and ventral tegmentum synthesize 
dopamine and distribute it via long axon pathways throughout the central nervous system. 
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Dopaminergic pathways consist of the nigrostriatal pathway and mesolimbic pathway 
(Kolb & Whishaw, 2015). The nigrostriatal pathway shuttles dopamine to the dorsal 
striatum, where it helps maintain normal motor control. The mesolimbic pathway carries 
dopamine to the nucleus accumbens and the prefrontal cortex. The nucleus accumbens is 
crucial to the reward system of the brain and motivation. The prefrontal cortex is 
responsible for complex cognitive functions such as planning, decision making, and 
social behavior. Decreases in dopamine availability in the mesolimbic pathway have been 
hypothesized to be the cause of deficits in decision-making, motivation, and 
reinforcement processes in ADHD (Sonuga-Barke, 2005; Volkow et al., 2009). Similar to 
studies showing reduced grey matter in adolescents with ADHD, slower development and 
pruning of neuronal pathways to the caudate nucleus (within the basal ganglia) was also 
observed in the brains of adolescents with ADHD. These differences disappeared or were 
negligible by the time these adolescents reached early adulthood (Rubia et al., 2014; Silk 
et al., 2009;).  
The existing body of research into brain structure and function in ADHD is 
somewhat limited by small sample sizes, but interest continues to grow in imaging 
studies as a way to better understand the disorder (Rubia et al., 2014). ADHD is 
associated with structural and functional differences from typically developing brains in 
the frontal lobe, striatum, basal ganglia, and dopaminergic systems is associated with 
ADHD (Fassbender et al., 2015; Rubia et al., 2014; Shaw et al., 2007; Solanto et al., 
2009; Sonuga-Barke, 2005; Volkow et al., 2009; Wiers et al., 2018).  
Genetics of ADHD Genetic studies have found polymorphisms in genes 
responsible for encoding proteins of the dopamine transporter (DAT1) and the dopamine 
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receptors (D2 and D3) to be related to ADHD (Wiers et al., 2018). These proteins are 
responsible for dopamine reuptake from the synaptic cleft and uptake of dopamine into 
the postsynaptic neuron (Volkow et al., 2009). Stimulant medications prescribed for 
ADHD are thought to be effective because they work to increase the availability of 
dopamine in the synaptic cleft (Weirs et al., 2018). Studies have shown that higher levels 
of DAT1 available in the striatum are associated with better treatment response to 
stimulant medications in adults with ADHD (Krause, 2008).  
 The alleles associated with ADHD are commonly found in the general population 
and, therefore, lack the specificity necessary to represent a “biomarker” for ADHD. One 
line of research has explored epigenetic markers that could explain the interaction 
between genes and environment that impacts dopaminergic processes in ADHD. 
Epigenetic studies have found the methylation or expression of DAT1 gene in blood cells 
is associated with DAT availability in the striatum and substantia nigra as measured by 
positron emission tomography, and tissue and blood samples taken during postmortem 
autopsies of primate brains and the brains of humans with ADHD (Rajala et al., 2014; 
Weirs, 2018).  
Brain changes in response to medication and psychotherapeutic treatment. 
Researchers use brain imaging techniques to examine changes in the structure of the 
brain as a way to measure treatment outcomes for psychotherapy and medications. These 
studies generally measure brain changes through prettreatment and posttreatment imaging 
or examining the relationship between pretreatment imaging and posttreatment measures 
of response to treatment. The efficacy of treatments for a wide variety of psychological 
disorders, including ADHD, has been investigated using these methods (Weingarten & 
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Strauman, 2015). Imaging studies of brains before and after receiving psychotherapeutic 
interventions or prolonged psychostimulant use have observed a normalizing effect, 
whereas the brains of those with ADHD become more similar to the brains of typically 
developing individuals.  
For example, one study examined the efficacy of a “summer camp” style token 
economy program for children with ADHD. ADHD and control children without ADHD 
had functional MRI images taken during a go/no-go task before and after living and 
participating in the activities of the behavioral treatment program for ten days. Control 
children’s inhibition greatly improved post treatment, but the ADHD children’s 
performance did not significantly improve. The functional MRI images (fMRI) taken 
during the pretreatment administration of the go/no-go task revealed activation of the 
anterior cingulate cortex, right caudate nucleus, and dorsal lateral pre frontal cortex 
(DLPFC) bilaterally in both groups. However, activation in these areas pretreatment was 
higher in the controls compared to the ADHD group. Posttreatment, the between groups 
differences in fMRI brain activation in these regions were nonsignificant, with the 
ADHD children showing only slight, nonsignificant improvement in reaction time 
variability (a measure of basic attention) from pretreatment levels (Siniatchkin et al., 
2012).  
 In another study, adults with ADHD who received 12 weekly sessions of CBT 
demonstrated improvements in brain connectivity and reduction in ADHD 
symptomatology. MRI imaging following treatment observed increased functional 
connectivity between the frontal-parietal network, the cerebellum and superior parietal 
lobule, as well as decreased self-reported ADHD symptoms. Increased bilateral 
ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO         34 
connectivity in the superior parietal lobule was significantly and negatively correlated 
with ADHD symptoms severity, indicating impaired connectivity in the superior parietal 
lobule may play a key role in ADHD and its amelioration (Wang et al., 2016).  
Imaging studies examining the effect of psychostimulants on those with ADHD 
consistently find that stimulant use alters the structure and function of the brain. A 
literature review found 29 published imaging studies on changes to the structure and 
function of the brain in ADHD related to stimulant medication use. All studies examining 
structural differences between unmedicated participants with ADHD and control groups 
without ADHD found structural abnormalities in the brains of those with ADHD. 
Stimulant medication use was associated with attenuation of these structural 
abnormalities in many of the brain regions examined. The most consistent finding 
between these studies found stimulant use to treat ADHD was associated with greater 
volume of white matter in all lobes of the brain, and grey matter in the anterior cingulate 
cortex and splenium of the corpus callosum (Spencer et al., 2013). The majority of the 
functional imaging studies found that participants with ADHD demonstrate less 
activation in the striatum (including caudate and putamen), anterior cingulate cortex, and 
prefrontal cortex when subjected to tasks that require prolonged use of attention, 
executive functioning, or emotion regulation. These structural differences in the brains of 
those with ADHD were negligible from control groups following prolonged treatment 
with stimulant medications (Spencer et al., 2013).  
Research into brain changes following interventions for ADHD demonstrated that 
those with ADHD exhibit less activation of the regions of the brain and neural networks 
involving attention, working memory, sensory integration and dopamine production. This 
ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO         35 
reduced activation can be ameliorated by evidence based-psychotherapy and treatment 
with stimulant medication, however these functional improvements do not always lead 
directly to improved ADHD symptomatology (Siniatchkin et al., 2012; Spencer et al., 
2013; Wang et al., 2015).  
Neuropsychological Functioning in SCT and ADHD 
Although slow or inefficient cognitive abilities is considered one of the key 
features of SCT, research has produced mixed results when examining the relationship 
between SCT and various measures of cognitive abilities (Bauermeister et al., 2012; 
Becker & Barkley, 2018). Researchers have compartmentalized and operationalized 
cognitive abilities into a variety of domains such as executive functioning, working 
memory, and processing speed. Poor performance on measures of these constructs 
indicates that an individual’s cognitive functions are notably slower or inefficient 
compared to the general population. This cognitive impairment is attributed to structural 
and functional differences in the brain that alters the way it functions compared to 
typically developing individuals. 
Facets of cognitive functioning such as learning, working memory, processing 
speed, attention, visual-spatial skills, motor coordination, and verbal reasoning are 
believed to be localized to specific regions of the brain. Complex collaboration among 
these interdependent regions enables the brain to produce the sophisticated behaviors and 
thoughts that make up the human experience. Dysfunction or injury in one or more of 
these regions interrupts these interdependent processes and can influence or impair one’s 
cognitive or behavioral functioning (Lezak et al., 2012). Thus, brain imaging technology 
can offer detailed images of alterations to the structure and function of the brain that 
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illuminate the neurological substrates of ADHD and explain some neuropsychological 
functioning.  
Neuropsychological tests offer ways to measure broad concepts such as general 
intelligence or specific cognitive processes. One of the most widely accepted 
neuropsychological batteries is the Wechsler Adult Intelligence Scale - Fourth Edition 
(WAIS-IV). Completion of the standard test battery on the WAIS-IV produces a score of 
general intelligence and index scores representing the strength of processing speed, 
working memory, verbal ability, and perceptual reasoning compared to an age matched 
population sample.  
A variety of neuropsychological measures exist that infer impairment in cognitive 
functioning through observation of an individual’s performance on a task (Lezak et al., 
2012). A meta-analysis of studies comparing participants with ADHD and control groups 
found performance on several neuropsychological measures to differ significantly. 
Specifically, the participants with ADHD consistently performed worse on the Trails A 
and Trails B test, which are neuropsychological measures of processing speed and 
executive functioning, respectively (Hervey et al., 2004; Reitan, 1993). Their 
performances on the digit span, digit symbol coding (Coding task), and arithmetic tests 
from the WAIS (measuring processing speed and working memory) were significantly 
worse with ADHD than the control groups’ (Hervey et al., 2004; Wechsler, 2008;).  
These neuropsychological measures of executive functioning, processing speed, 
and working memory held large to medium weighted effect sizes (Hervey et al., 2004). 
Whereas these particular measures held substantial effect sizes across studies, many other 
neuropsychological measures of working memory, processing speed, and executive 
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functioning had negligible findings across these studies. This pattern of inconsistent 
findings across neuropsychological measures that purportedly measure the same 
cognitive function was true for measures of attention, memory, and motor speed as well. 
These findings indicate that no single cognitive function is attributable to ADHD. Rather, 
those with ADHD exhibit widespread neuropsychological deficits and variability in 
multiple domains of cognitive functioning (Hervey et al., 2004).  
SCT and Neuropsychological Functioning  
There is a dearth of studies examining the relationships between SCT and 
measures of working memory and processing speed (Jacobson et al., 2018). One study 
examined children and adolescents with ADHD-IN and typically developing children and 
adolescents. Parents’ ratings of their children’s SCT symptoms and the participants’ 
processing speed index (PSI) scores on the Wechsler Intelligence Scale for Children were 
used in this analysis. All participants’ SCT ratings were factor analyzed, producing three 
factors consistent with the sleepy/sluggish, daydreamy, and low initiation symptom 
domains of SCT. The day dreamy and low initiation factors were significantly inversely 
associated with PSI scores with a small effect size, indicating SCT symptoms partially 
reflect “sluggishness” in their cognitive processes (Jacobson et al., 2018). 
A study of SCT and ADHD in Puerto Rican children utilized mothers’ and 
teachers’ collateral report ratings of the participants’ behavior and ADHD 
symptomatology and neuropsychological measures. The authors combined multiple 
collateral report and neuropsychological measures of behavior and cognitive functioning 
into composite scores that represented the participant’s ability in different cognitive 
domains. These composite scores included measures of working memory, processing 
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speed, memory retrieval, interference control, and planning/problem solving. Separate 
confirmatory factor analyses were conducted for the teacher ratings and parent ratings of 
ADHD and SCT symptomatology to confirm the parent rating were accurately reflecting 
the inattentive, hyperactive/impulsive, and SCT domains of ADHD. Contrary to 
expectations, SCT was not associated with any of the collateral reports of cognitive 
functioning or executive functioning measures (Bauermeister et al., 2012). On the other 
hand, strong associations were found between ADHD-In symptoms and many of the 
cognitive functioning measures used. The authors acknowledged these relationships 
between inattention and cognitive functioning were not controlled for in the analyses, and 
may have overshadowed SCT’s relationships with the cognitive functioning measures 
(Bauermeister et al., 2012).  
Another cause for these disparate findings may be in the types of measures used 
to create the composite scores. The working memory composite was derived from 
neuropsychological measures of verbal working memory for numeric information, 
nonverbal working memory for spatial information, and nonverbal working memory for 
motor sequencing. In a similar way, the processing speed composite was derived from 
neuropsychological measures of rapid naming of stimuli, speeded motor, and 
nonlinguistic processing speed. It is possible SCT’s lack of associations with the 
processing speed and working memory composites is due to the measures used to build 
these composites examining different loosely related functions rather than representing 
one uniform cognitive function (Bauermeister et al., 2012).  
 Kamradt et al. investigated the differences between adults with minimal, 
moderate, or severe levels of SCT in their anxiety, internalizing symptoms, and 
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externalizing symptoms. They also compared these groups on their performance on 
measures from a battery of neuropsychological tests. The three groups did not differ in 
their performance on measures of inhibition, interference control, vigilance, or sustained 
attention. Only those in the moderate SCT group exhibited significantly worse working 
memory (measured by performance on the WAIS-IV Digit Span task) compared to both 
the severe and mild SCT groups. This finding is unusual because it implies a parabolic 
relationship between SCT and working memory. One explanation for this finding put 
forth by the study’s authors suggests that those with moderate SCT may be at particular 
risk for working memory impairment due to subtle diffuse neuropsychological 
impairment culminating to impair working memory (Kamradt et al., 2018).  
Utility of Neuropsychological Testing for ADHD and SCT 
The extant literature demonstrates inconsistency in the relationships between both 
ADHD and SCT and a variety of neuropsychological measures, especially those of 
working memory and processing speed. Although standardized neuropsychological 
measures are generally considered crucial to accurately measure cognitive functions, the 
validity of neuropsychological testing for diagnosing of ADHD has been called in to 
question. Prior research has found between 35% and 87% of those who meet DSM 
criteria for ADHD show no impairment on neuropsychological measures. As a result, the 
false negative rate of most neuropsychological measures is too high to be used as a 
diagnostic measure for ADHD (Barkley, 2019; Matier-Sharma et al., 1995; Ramsay, 
2015). Clinicians advocating for best practices in the diagnosis of ADHD and SCT argue 
that clinical interviews and self-report measures of executive functioning are more 
ecologically valid tools for identifying the difficulties those with ADHD and SCT face 
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and have better predictive power (Barkley, 2011b, 2019; Barkley & Fischer, 2011; 
Pettersson et al., 2018). Although neuropsychological measures may not be the best way 
to diagnose ADHD in adults, these measures still provide valuable information on 
cognitive deficits, language issues, effort, and other potential issues that can affect 
learning and occupational functions and may, therefore, be more useful for identifying 
deficits and treatment planning, than diagnosis alone (Mapou, 2019).  
Executive Functioning 
Researchers examining the construct of executive functioning have defined it in 
different but closely related ways. Conceptualizations of executive functioning have 
attributed a variety of cognitive processes and abilities to executive functioning including 
goal-directedness, time management, hindsight, self-consciousness, inhibition, 
motivation, problem solving, interference control, and cognitive flexibility. As previously 
mentioned, executive functioning is a set of top-down mental abilities that requires the 
collaboration of different cognitive and neuropsychological processes. These processes 
work together to help an individual monitor and regulate behavior over time towards the 
achievement of a goal or to solve a novel problem. In other words, executive functioning 
determines how effective one is at accomplishing what they set out to do. (Barkley, 
2011b; Diamond, 2013). Core aspects of executive functioning recognized by the 
National Institutes of Health are inhibition (self-control and resisting the urge to act 
impulsively), interference control (selective attention and cognitive inhibition), working 
memory, and cognitive flexibility (creative thinking and quickly and flexibly adapting to 
changing circumstances; Diamond, 2013).  
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 Executive functioning deficits have been implicated in a variety of mental health 
disorders including addiction, conduct disorder, depression, obsessive compulsive 
disorder, schizophrenia, and ADHD. Executive functioning deficits have also been 
observed to be associated with social and physiological problems including obesity, 
school performance, vocational success, marital discord, and even criminal behavior 
across multiple studies and populations (Diamond, 2013). Different patterns of executive 
functioning have been found to differently associate with both ADHD and SCT in adults 
(Barkley, 2011b, 2011c, 2012; Willcutt et al., 2005). 
The Barkley Deficits in Executive Functioning Scale (BDEFS) is a self- and 
other-report behavior rating scale developed to measure deficits in specific executive 
functioning domains and overall executive functioning in adults (Barkley, 2011b). These 
domains include self-management to time, self-organization/problem-solving, self-
restraint, self-motivation, and self-regulation of emotion (Barkley, 2011b). The BDEFS 
domains are functionally different from neuropsychological measures of executive 
functioning because it assesses how dysfunction in executive functioning causes 
problems in everyday life over the past six months. Neuropsychological measures of 
executive functioning indicate how individuals perform on an executive functioning task 
in a controlled setting, typically for no longer than 30 minutes and may, thus, lack the 
external validity found in the BDEFS. Nonetheless, all BDEFS domains were largely 
found to be mildly to moderately correlated with several neuropsychological measures of 
cognitive functioning such as the Digit Span task from the WAIS-III, Conners’ 
continuous performance task, and Stroop color word task (Barkley, 2011b; Smith et al., 
2013).  
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The BDEFS domains were largely unrelated to measures of intelligence or 
academic achievement, with the exception of the deficits in self-organization/problem-
solving domain holding a weak negative relationship with full scale IQ on the WAIS-IV 
(Barkley, 2011b). Preliminary research on the BDEFS found significantly more adults 
with ADHD rated themselves as having clinical levels of impairment in executive 
functioning than a clinical control group and a community control group (Barkley, 
2011b). In another test comparing executive functioning tests and rating scales, the 
BDEFS and other tests of executive functioning were administered to adults with ADHD, 
adults who had ADHD in childhood that remitted in adulthood, and individuals who 
never exhibited symptoms of ADHD. Of these measures of executive functions, only the 
five subscales of the BDEFS were sensitive to differences between those with current 
ADHD from those whose symptoms remitted after childhood (Barkley, 2011b). These 
findings indicate the BDEFS holds good construct and discriminant validity, and is an 
ecologically valid measure of executive functioning deficits (Barkley 2011b, 2019). 
Executive Functioning in ADHD and SCT 
Barkley examined the differences in executive functioning between ADHD and 
SCT by comparing subscale scores on the BDEFS of groups of adults with ADHD only, 
SCT only, both ADHD and SCT, and a control group. The SCT-only group and the 
ADHD and SCT group both reported worse self-organization and problem solving 
abilities than the control or ADHD-only group. The combined ADHD and SCT group 
scored the lowest on the subscales of self-management to time, self-restraint, self-
motivation, and self-regulation of emotion (Barkley, 2012). Stepwise regression analysis 
examined how much the participant’s symptom ratings of SCT, ADHD-In, and ADHD-
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H/I contributed to the variance in executive functioning subscale scores. SCT symptoms 
contributed the most variance in Self-Organization and Problem-Solving (54.5%), Self-
Discipline (45.8%), and Self-Regulation of Emotion (44.5%), with ADHD-IN explaining 
less than 9% of the variance for each. ADHD-In symptoms contributed the most variance 
to Self-Management to (54.5%) and Self-Motivation (48.8%) with SCT symptoms 
explaining less than 5% of the variance for each (Barkley, 2012).  
One study utilizing a nonclinical sample of college students explored the 
relationship between SCT scores on the BAARS-IV, executive functioning scores on the 
BDEFS, study skills, and general functional impairment. Path analyses were conducted to 
control for the influence of demographic information, anxiety, and depression, and 
ADHD symptoms on the relationships between SCT, executive functioning, study skills, 
and general functional impairment. SCT remained significantly associated with executive 
functioning deficits, poorer study skills, and general functional impairment. Two 
regression models examined the relative contribution of anxious, depressive, SCT, and 
ADHD symptoms as well as demographic information in predicting executive 
dysfunction. These analyses found that adding SCT to the model reduced the association 
between depressive symptoms and executive functioning to nonsignificance. Moreover, 
adding SCT to the model dramatically reduced the relationship between ADHD-In 
symptoms and executive functioning. In fact, SCT emerged as the strongest predictor of 
executive functioning deficits and added an additional 6% to the variance in executive 
functioning (Flannery et al., 2017).  
The previously mentioned study by Leikauf and Solanto (2017) examined 
differences in relationships between SCT, ADHD symptoms, and a measure of executive 
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functioning in medicated and unmedicated adults with ADHD. They used self-report 
form of the BDEFS to measure executive functioning, self-report form of the BAARS-IV 
to measure SCT, the STAI and BDI-II to measure depression, and the Conners Adult 
ADHD Rating Scale-Self-Report (CAARS) to measure ADHD symptoms. In 
unmedicated participants, strong and significant correlations were observed between SCT 
scores and the BDEFS Summary score as well as between ADHD symptoms and the 
BDEFS Summary score. However, in the medicated group ADHD symptoms were not 
significantly correlated with the BDEFS Summary score. Only the self-restraint score 
was significant for those taking stimulant medications. SCT was a better predictor of 
overall executive functioning impairment, “above and beyond,” ADHD or depression for 
both medicated and unmediated participants. These results seem to imply that, when 
ADHD symptomatology was reduced or managed by stimulant medication, the 
relationship between SCT and executive functioning persisted (Leikauf & Solanto, 2017).  
In studies using the BDEFS to examine executive functioning’s relationships with 
SCT and ADHD, SCT was found to be a significant predictor of deficits in all executive 
functioning domains on the BDEFS, even when controlling for confounding factors such 
as ADHD, internalizing symptoms, and demographic information (Jarrett et al., 2017; 
Leikauf & Solanto, 2017). These findings indicate that the BDEFS is a good measure of 
executive functioning impairment in those with both ADHD and SCT.  
These studies demonstrate inconsistency and complexity in the relationships of 
ADHD and SCT to a variety of measures of neuropsychological and cognitive 
functioning, including measures of executive functioning, working memory, and 
processing speed. However, some measures of these constructs have demonstrated more 
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consistent relationships with SCT and ADHD than others. A meta-analysis of 
neuropsychological measures’ relationships with ADHD by Hervey et al., found the 
subtests from the processing speed index and working memory index of the WAIS-IV 
consistently demonstrated significant large effect sizes in its associations with ADHD. 
The executive functioning domains measured by the BDEFS consistently demonstrated 
unique and independent relationships with ADHD and SCT symptomatology (Barkley, 
2011b; Barkley, 2012; Flannery et al., 2017; Jarrett et al., 2017; Leikauf & Solanto 2017). 
These relationships are independent the association of SCT with classic ADHD 
symptomatology, and in some studies, SCT was a greater predictor of cognitive 
functioning than ADHD symptoms. According to Leikauf and Solanto (2017), “overall, 
these results demonstrate that SCT in adults is not exclusively a proxy for ADHD 
symptom severity or internalizing symptomatology” (p. 709), but rather represents its 
own syndrome that predict deficits in cognitive functioning. 
Summary of Literature Review 
SCT and ADHD are two highly related disorders that co-occur in 46% of all cases 
of ADHD and 54% of all cases of SCT (Barkley, 2012). SCT symptomatology shares 
many features with the inattentive subtype of ADHD, but extensive testing has 
demonstrated that these disorders are distinct from one another (Barkley, 2011a, 2012; 
Becker et al., 2016; Becker & Barkley, 2018; Becker, Marshall, & McBurnett, 2014; 
Garner et al., 2010; Wåhlstedt & Bohlin, 2010).  
SCT scores are, independently of ADHD symptoms, associated with impairment 
in social, academic, and emotional functioning (Becker & Barkley, 2018). SCT was also 
associated with internalizing symptoms, such as depression and anxiety, when controlling 
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for ADHD symptomatology (Bauermeister et al., 2012; Becker, Langberg, et al., 2014; 
Carlson & Mann, 2002; Kamradt et al., 2018). In some instances, SCT held stronger 
relationships with internalizing symptomatologythan ADHD (Becker, Langberg, et al., 
2014). This relationship between SCT and internalizing disorders may be due to shared 
features of these disorders such as apathy, rumination/daydreaming, inactivity, and 
decreased effort (Smith & Langberg, 2017). High levels of effortful control and low 
stress levels are protective factors against internalizing disorders (Gulley, et al., 2017).  
Both ADHD and SCT have been shown to be associated with impairment in a 
variety of neuropsychological and cognitive domains, such as executive functioning, 
working memory, processing speed, attention, and memory. However, these relationships 
are inconsistent and vary in significance and effect size from study to study 
(Bauermeister et al., 2012; Hervey et al., 2004; Jacobson et al., 2018; Kamradt et al., 
2018). This is possibly due to the limited utility of neuropsychological measures in these 
populations and diffuse deficits across multiple neuropsychological and cognitive 
domains in both ADHD and SCT (Barkley, 2019; Hervey et al., 2004; Mapou, 2019).  
Hypothetical Models of SCT 
The process model of depletion argues that an individual’s self-control wanes as 
their motivation and attention shifts away from goal directed behavior (Inzlicht & 
Schmeichel, 2012). External manipulations of motivation have been shown to reduce the 
impairment in basic attention in those with ADHD, as posited by this model (Dekkers et 
al., 2017; Inzlicht & Schmeichel, 2012). Second, conceptualization of ADHD and SCT in 
Posner’s model of attention argues that SCT is characterized by deficits in the orienting 
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stage of attention, whereas ADHD is the product of deficits in the alerting, orienting, and 
executive functioning aspects of attention (Barkley, 2016; Becker & Willcutt, 2018). 
In light of these two theories and research on the relationships between ADHD 
and SCT, SCT symptomatology may be the product of interactions between internalizing 
symptomatology and impaired cognitive functioning. Consider the case of a hypothetical 
individual who experiences impairment in working memory and processing speed, with 
comorbid internalizing symptoms. When a situation or task that requires mental effort 
arises, their impaired cognitive functions are already taxed by internalizing 
symptomatology, reducing their capacity to orient to the new situation and decreasing 
their motivation to expend further effort to engage with the new situation or fully exercise 
their executive functions. Internalizing symptoms such as anxiety, depression, somatic 
complaints, and traumatic stress may lead to rumination (daydreaming about negative 
emotional experiences) and require sustained effort to cope with the negative aspects of 
these symptoms. These consequences are reflected in the day dreamy and low initiation 
aspects of SCT (Jacobson et al., 2018). Following this logic, SCT may be better 
conceptualized as a transdiagnostic factor that is present in individuals with 
neuropsychological impairments or a separate neurodevelopmental disorder in its own 
right. 
SCT could also be conceptualized as a syndrome whose symptoms reflect deficits 
in executive functions and the internalization of these challenges. The theory of TDFs 
posits that underlying mental health problems express themselves as different mental 
health disorders with different symptoms according to an individual’s personal 
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characteristics and life experiences. A commonly accepted TDF paradigm is the 
internalization or externalization of negative affect (Krueger & Eaton, 2015). 
Multiple researchers have proposed that deficits in a specific executive function 
or broad deficits in executive functioning are the source of the inattentive, hyperactive, 
and impulsive symptoms of ADHD (Willcutt et al., 2005). A study of SCT and ADHD 
found SCT contributed the majority of the variance to the Self-Organization and 
Problem-Solving, Self-Discipline, and Self-Regulation of Emotion subscales of the 
BDEFS , whereas inattentive symptoms of ADHD explained less than 9% of the variance 
for each. Inattentive symptoms explained the majority of the variance for the remaining 
Self-Management and Self-Motivation subscales, whereas SCT explained less than 5% of 
the variance for each (Barkley, 2012). Perhaps deficits in these or other specific executive 
functions are also the source of the symptoms of SCT.  
Considering SCT and executive dysfunction in the context of internalization of 
mental health challenges, it is theoretically possible that SCT represents a novel 
internalizing expression of executive dysfunction. The hyperactive and impulsive 
symptoms of ADHD may reflect an externalization of executive dysfunction or 
inhibition, whereas the inattentive symptoms could reflect an internalization of executive 
dysfunction or inhibition. If an individual is experiencing executive dysfunction in 
organization, self-discipline, or emotion regulation and they have a tendency to 
internalize their problems, their unique blend of personal characteristics and life 
experiences may result in SCT symptomatology. This could also partially explain SCT’s 
strong relationships with internalizing symptoms. An internalizing disorder such as 
depression reflects the internalization of negative affect. In the same way, SCT may 
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reflect internalization of executive dysfunction. An individual who has a tendency to 
internalize their problems would be more likely to develop an internalizing mood 
disorder, such as depression, and internalize their executive dysfunction, which could be 
expressed as SCT.  
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Chapter 3: Method 
The study examined the relationships between SCT, ADHD, cognitive 
functioning, and internalizing symptoms in adults diagnosed with ADHD, employing a 
combined cross-sectional between subjects design and correlational/regression design 
using existing data.  
Participants 
This study utilized existing data collected from 143 adult subjects who have 
previously received a psychological assessment at a university-based, adult ADHD 
outpatient specialty clinic in a large urban area located in the Northeastern United States. 
Inclusion and Exclusion Criteria  
This study examined existing data. Subjects were those 18 years old or older 
assessed at intake by clinician rating to meet the full symptom criteria for the Inattentive, 
Hyperactive/Impulsive, or Combined subtype of ADHD, as well as those who meet 
criteria for SCT. ADHD criteria were established by the Conners Adult ADHD Rating 
Scale - Self-Report (CAARS), and clinician ratings on the Structured Clinical Interview 
for DSM-5 Disorders (SCID-5). SCT criteria were established by the SCT subscale of the 
BAARS-IV.    
Individuals diagnosed with severe psychiatric issues, such as a co-occurring 
psychotic disorder and severe current substance use disorders, as established by the 
SCID-5 administered as part of the psychological assessment, clinician rating, or 
previous diagnosis, were excluded from the study. Of the 143 subjects, only three met 
criteria for moderate substance use disorders. Substance use disorders have been 
identified as commonly occurring in individuals with ADHD (Zulauf, Sprich, Safren, & 
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Wilens, 2014). These individuals were retained for the analyses because vulnerability to 
substance use disorders is an important part of the ADHD profile.  
Measures of ADHD and SCT Symptoms 
Barkley Adult ADHD Rating Scales-Fourth Edition (BAARS-IV)  
The BAARS-IV is a 27 item scale, available in self- and other-report rating 
versions, designed to measure the symptoms of ADHD (Barkley, 2011a). The items are 
organized into four subscales: three that correspond with the DSM-IV inattentive, 
impulsive, and hyperactive symptoms of ADHD, and a fourth that measures the 
symptoms of SCT. Scores on the inattentive and SCT subscales can range from 9 to 36, 
with higher scores indicating greater levels of symptomatology. Scores on the 
hyperactive subscale range from 5 to 20. Scores on the impulsive subscale range from 4 
to 16. Higher scores on a subscale of the BAARS-IV reflect a greater number and/or 
magnitude of endorsed symptoms of ADHD or SCT. Participants and an informant of 
their choice are asked to rate the frequency with which the participant engages in or 
experiences each of the symptoms of ADHD or SCT from 1 (never or rarely) to 4 (very 
often).  
Subjects’ responses on the four BAARS-IV subscales are summed to create a total 
raw score for each subscale. The raw score is used to calculate a statistic reflecting each 
subject’s percentile rank compared to others in the same age group for each symptom 
domain. A subject’s percentile score represents the portion of individuals in the 
normative sample the individual scored higher than on the subscale. Scores in the 93rd 
percentile or higher reach clinically significant levels of the symptom domain and 
indicate the presence of ADHD or SCT (Barkley, 2011a).  
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The BAARS-IV subscales were used to operationalize ADHD and SCT in two 
ways. Analyses examining ADHD and SCT symptoms from a continuous perspective 
used subjects’ percentile ranks for each symptom domain. Analyses that conceptualized 
ADHD symptom domains and SCT from a categorical perspective will use the 93rd 
percentile score on each symptom domain as a cutoff score for identifying clinically 
notable levels of the symptom domain (Barkley, 2011a, 2012). The BAARS-IV subscales 
were found to have satisfactory internal consistency (Cronbach’s α ranged from 0.776 to 
0.914) and test-retest reliability (0.66-0.76; Barkley, 2011a). Further testing of the 
BAARS-IV using Widaman’s (1985) method supported convergent validity with a DSM-
IV checklist of childhood ADHD (X2 = 903.0, p < 0.001) and discriminant validity 
between self and informant forms of the BAARS-IV (X2= 1166.9, p = 0.01) using 
multitrait multimethod approach (Leopold et al., 2015). 
Conners Adult ADHD Rating Scale - Self-Report (CAARS) 
The CAARS is a 66-item self-report measure designed to examine the symptoms 
of ADHD in adults. Participants respond to each item by rating themselves from 0 (not at 
all, never) to 3 (very much, very frequently) based on their level of agreement with each 
item or their reported frequency of the behavior described by each item. The items on the 
CAARS contribute to four scales, that measure common symptoms of ADHD, as well as 
three scales that reflect the DSM-IV symptom criteria for ADHD. The DSM-IV 
Inattentive Symptoms subscale and DSM-IV Hyperactive/Impulsive Symptoms subscale 
were used as continuous measures to operationalize the symptoms of ADHD. This 
allowed for the severity of the subjects’ inattentive and hyperactive/impulsive 
symptomatology to be measured continuously rather than merely identifying whether or 
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not they meet criteria for an ADHD diagnosis. Scores on the DSM-IV Inattentive 
Symptoms subscale and IV Hyperactive-Impulsive Symptoms subscale range from 0 to 
27, with higher scores indicating higher levels of ADHD symptomatology. The raw 
subscale scores are converted to T scores, with a T score of 65 or greater indicating 
clinically notable levels of the symptoms domain. The DSM-IV Inattentive Symptoms 
subscale and IV Hyperactive-Impulsive Symptoms subscale of the CAARS have been 
found to have excellent discriminant validity; comparison study of adults who met DSM 
criteria for ADHD and an age- and gender-matched control group who did not meet DSM 
criteria for ADHD found these subscales had an 85% correct classification rate (Conners 
et al., 1999). 
Measures of Internalizing Symptoms 
Internalizing symptoms are operationally defined as scores on the BDI-II, Penn 
State Worry Questionnaire (PSWQ), the Affect subscale of the BADDS, and Neuroticism 
scale of the NEO-PI-R. In several studies, these measures of internalizing symptoms have 
demonstrated good convergent validity, with significant moderate relationships among 
them. In a prior study using data from the same university-based adult ADHD outpatient 
specialty clinic, the Neuroticism scale of the NEO-PI-R had good convergent validity 
with the PSWQ (R2 = 0.294, p < 0.08) and the BDI-II (R2 = 0.343, p < 0.08; Serine, 
2016). The Neuroticism scale has also been found to be associated with difficulty 
regulating emotions as measured by the Affect scale of the BADDS (R2 = 0.388, p < 
0.001; Di Nicola et al., 2014). In a study of internalizing symptoms a sample of 
Caucasian and African American adults, scores from the BDI-II were significantly related 
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to scores on the PSWQ (R2 = 0.30, p < 0.01; Chapman, Kertz, & Woodruff-Borden, 
2009).  
Brown Attention Deficit Disorder Scale - Adult Version (BADDS) 
The BADDS is a 40-item self-report scale designed to screen for common 
difficulties and core features of the Inattentive symptoms of ADHD, based on the 
executive dysfunction model of ADHD (Brown, 1996; Brown & Whiteside, 2003). The 
BADDS is unique among measures of adult ADHD in that it identifies both ADHD 
symptomatology and signs of executive dysfunction that those with ADHD sometimes 
face. Each item on the BADDS describes a problem or symptom associated with ADHD. 
Participants rate how much each item has been a problem for them in the past 6 months 
from 0 (never) to 3 (almost every day). Each item on the BADDS contributes to a total 
score as well as one of five subscale scores, which measure difficulty (a) activating or 
organizing for work, (b) sustaining attention , (c) sustaining mental effort on boring or 
difficult tasks, (d) managing affect and emotion that could interfere with work, and (e) 
problems with working memory or recall. Only the affect subscale of the BADDS 
(BADDS-Affect) was used in these analyses as a measure of participants’ capacity to 
regulate their internalizing symptoms in the analyses. Raw scores on the BADDS-Affect 
can range from 0 to 21. This score is converted to a T score, with T scores of 65 or 
greater indicating clinically notable levels of difficulty managing affect and emotion The 
BADDS has demonstrated satisfactory test-retest reliability (r = 0.87) and excellent 
internal consistency (Cronbach’s α = 0.96; Brown & Whiteside, 2003). The Affect 
subscale has demonstrated good convergent validity with the Internalizing problems 
subscale of the Behavior Assessment System for Children (R2 = 0.52), and the Emotional 
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Control subscale of the Behavior Rating Scale of Executive Function (R2 = 0.66; Brown, 
1996). 
Penn State Worry Questionnaire (PSWQ) 
The PSWQ is a self-report measure designed to measure the severity of worry 
(Meyer et al., 1990). Participants respond to a series of 16 items on their tendency to 
worry, rating the statements from 1 (not at all typical of me) to 5 (very typical of me). 
Five of the items are reverse scored. Scores on the PSWQ range from 16 to 80. Higher 
total scores represent greater frequency and severity of worry. The PSWQ was used to 
measure the anxiety and worry component of internalizing symptoms in the planned 
analyses. Individuals with ADHD may underreport their level of impairment on self-
report measures due to a lack of self-awareness on their behavior (Manor et al., 2012). By 
focusing on worry rather than other behavioral features of anxiety, the PSWQ has higher 
construct validity for those with ADHD than other measures of anxiety (Meyer et al., 
1990). The PSWQ has demonstrated good internal consistency (Cronbach’s α = .83-.93) 
and test-retest reliability (r = .74-.93) (Brown et al., 1992; Molina & Borkovec, 1994). 
The PSWQ has demonstrated good discriminant validity and captures features of 
generalized anxiety such as the apprehensive and uneasy symptoms of anxiety often 
expressed by those with co-occurring anxiety and ADHD (Meyer et al., 1990; Ramsay, 
2015).  
Beck Depression Inventory, Second Edition (BDI-II) 
The BDI-II is a 21-item self-report measure designed to assess severity of 
depression (Beck et al., 1996). Participants rate the severity of their depression by 
endorsing different statements grouped by key symptoms of depression such as sadness, 
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self-dislike, social withdraw, loss of appetite, irritability, feelings of guilt, suicidality, and 
anhedonia. These statements are rated from 0 to 3 and summed to create a total score. 
Scores on the BDI-II range from 0 to 63. Higher scores on the BDI-II represent more 
severe symptoms of depression. The BDI-II has demonstrated high internal consistency 
(Cronbach’s α = .91) and test-retest reliability (r = .93) (Beck et al., 1996). Further testing 
of the BDI-II found it demonstrates moderate to high convergent validity with the Short 
Form General Health Survey (R2 = 0.42, p < 0.01; Arnau et al., 2001).   
Revised NEO Personality Inventory (NEO-PI-R) 
The NEO-PI-R is a 240-item measure of the five personality domains in the five 
factor model of personality: Neuroticism, Openness, Extraversion, Agreeableness, and 
Conscientiousness. Items on the NEO-PI-R consist of statements about oneself that are 
rated on a Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). These 
items each contribute to subscale score reflecting one of the five personality domains. 
Scores on each subscale range from 0 to 192. These raw scores are converted to 
standardized T scores. T scores greater than 65 are in the very high range. T scores 
between 55 and 65 are in the high range. T scores between 45 and 55 are in the average 
range. T scores between 35 and 45 are in the low range. T scores below 35 are in the very 
low range (Costa & McCrae, 1992; Serine 2016). Internalizing behavior was assessed 
using the personality factor of neuroticismbecause it reflects symptoms of anxiety and 
depression as well as personality traits related to internalizing symptoms, such as self-
consciousness and feelings of vulnerability.  
Research on use of the NEO-PI-R in those with ADHD has found high 
neuroticism, low agreeableness, and low conscientiousness are common personality traits 
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shared among this population (Parker et al., 2004). The chronic restlessness and higher 
levels of physiological arousal characteristic of hyperactive symptoms of ADHD can be 
mistaken for anxiety by some measures (Meyer et al., 1990; Ramsay, 2015). The NEO-
PI-R measures stable personality traits and the cognitive aspects of anxiety and other 
internalizing symptoms (Costa & McCrae, 1992). This allows it to measure internalizing 
symptomatology, without being overly influenced by confounding physiological 
symptoms of hyperactivity. Multiple studies have demonstrated that the personality 
domains of the NEO-PI-R hold excellent convergent validity with other well established 
measures of similar personality traits. This includes the relationship between NEO-PI-R 
Extraversion and the Extroversion scale of the Myers Briggs Type Indicator (R2 = 0.55), 
NEO-PI-R Neuroticism and the Succorance scale of the Adjective Checklist (R2 = 0.36), 
and NEO-PI-R Conscientiousness and the Endurance scale of the Adjective checklist 
(R2 = 0.28; Costa & McCrae, 1992). The NEO-PI-R has also demonstrated good test-
retest reliability (r = 0.52 to 0.81) and interrater reliability (r = 0.86 to 0.95) across 
multiple studies (Costa & McCrae, 1992). 
Measures of Cognitive Functioning 
Cognitive functioning was operationally defined as subjects’ performance on the 
Coding task and Digit Span task of the WAIS-IV, and their Total Executive Functioning 
summary score of the BDEFS. These measures of cognitive functioning have 
demonstrated good convergent validity with one another, with small to moderate 
significant correlations ranging from .15 to .52 (Barkley 2011b; Wechsler, 2008).  
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Barkley Deficits in Executive Functioning Scale (BDEFS) 
The BDEFS is a behavior rating scale developed to measure deficits in executive 
functioning in adults. The 89 items each contribute to five subscale scores on the BDEFS. 
Each subscale represents a different aspect of executive functioning that contributes to 
impairment in daily life activities. There is also a BDEFS Total Executive Functioning 
Summary score (BDEFS Summary score). These subscales are (a) Self-Management to 
Time, (b) Self-Organization/Problem Solving, (c) Self-Restraint, (d) Self-Motivation, (e) 
and Self-Regulation of Emotion as well as a BDEFS Summary score. The latter is 
calculated by summing the responses to all of the items on the BDEFS. Higher scores on 
a subscale of the BDEFS reflect greater impairment of executive functioning. Scores on 
the Self-Management to Time subscale range from 21 to 84. Scores on the Self-
Organization/Problem Solving subscale range from 24 to 96. Scores on the Self-Restraint 
subscale range from 19 to 76. Scores on the Self-Motivation subscale range from 12 to 
48. Scores on the Self-Regulation of Emotion subscale range from 13 to 52. The BDEFS 
Summary score can range from 89-356. Higher scores reflect greater dysfunction in the 
executive functioning domain, whereas lower scores reflect intact executive functioning.  
 The BDEFS Summary score is calculated by summing all items. This is 
converted to a percentile rank based on a subject’s gender and age group. A subject’s 
percentile score represents the portion of individuals in the normative sample they scored 
higher than on the BDEFS. An ADHD-EF index score is calculated from the sum of 11 
items distributed throughout the measure that represent common executive functioning 
difficulties individuals with ADHD experience. The subscale scores, total executive 
functioning summary score, and ADHD-EF index score all demonstrated satisfactory 
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internal consistency (Cronbach’s α ranged from 0.958 to 0.842) and test-retest reliability 
(r ranged from 0.62 to 0.90; Barkley, 2011b). Research validating the BDEFS measure 
found it has good convergent validity with the Coding task from the WAIS-IV (R2 = 
0.27; Barkley, 2011b). Research examining the BDEFS and a measure of goal-directed 
selective attention in a sample of college students with ADHD found support for the 
discriminant validity of the BDEFS (Dehili et al., 2017).  
Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV) 
The WAIS-IV is an intelligence test battery designed to measure intellectual 
functioning in specific cognitive domains and general intellectual ability. Subjects were 
administered select subtests from the WAIS-IV as part of the ADHD evaluation process. 
This study used the Coding task and the Digit Span task as measures of impaired 
cognitive processes. The Coding task is a test of cognitive processing speed. The Digit 
Span task measures auditory working memory for numbers. Extensive testing has proven 
the reliability and validity of the WAIS-IV and its subtests in a variety of populations 
(Wechsler, 2008).  
Procedures 
This was a secondary analysis of data were gathered from new clients during 
intake at a university-based, adult ADHD outpatient specialty clinic in a large urban area. 
The aforementioned measures were completed as part of a comprehensive ADHD 
assessment. Research assistants and the administrators of the psychological assessment 
recorded the data from these measures, de-identified it, and copied the data into an SPSS 
data file. Human subjects research utilizing this data set was approved by a Institutional 
Review Board (IRB). Subjects had already completed the evaluation and signed a consent 
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form agreeing to let their private information be used in research studies and informing 
them of the minimal risk to the participants. This study utilized the data of participants 
who met the requirements of the inclusion and exclusion criteria collected between 
January 2014 and May 2019 for the analyses.  
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Chapter 4: Results 
Diagnostic Group Creation 
This study examined the relationship between ADHD, SCT, internalizing 
symptoms, and cognitive functioning. The sample consisted of 143 participants who 
presented for a comprehensive evaluation at an adult ADHD outpatient specialty clinic. 
Data were analyzed across the following four diagnostic subgroups: ADHD + SCT, 
ADHD + subclinical SCT, ADHD only, and SCT only; they could be distinguished from 
one another based on the degree of self-reported internalizing symptoms and impaired 
cognitive functioning. The study also examined which co-occurring internalizing 
symptoms and aspects of cognitive functioning were most predictive of SCT. 
These four groups were created by sorting the participants according to their score 
on the SCT subscale of the BAARS-IV. Cutoff percentile scores for each group were 
determined by following Barkley’s validation research on the BAARS-IV, which found 
the SCT subscale scores at the 93rd percentile or higher reflected clinically significant 
levels of SCT symptomatology (2011a). Those whose SCT scores were in the Borderline 
range as outlined in the BAARS-IV manual (85th to 92nd percentile) do not meet criteria 
for SCT, while still having notable levels SCT symptomatology. This range of scores 
reflects subclinical levels of SCT (Barkley, 2011a).  
The ADHD + SCT group consisted of participants who met or exceeded the 93rd 
percentile for their reference age group on the SCT subscale (the threshold for clinically 
significant levels of SCT outlined in the BAARS-IV manual) and met criteria for an 
ADHD diagnosis, as determined by the CAARS and SCID-5, which was part of the 
original comprehensive evaluation. Seventy-four subjects from the data set met criteria 
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for ADHD + SCT and had all relevant data needed to conduct the analyses. The ADHD + 
subclinical SCT group consisted of 36 subjects whose SCT subscale scores were between 
the 85th and 92nd percentile for their reference age group, received an ADHD diagnosis, 
and had all relevant data needed to conduct the analyses.  
The ADHD-only group consisted of 26 subjects who received an ADHD 
diagnosis, their SCT subscale score was below or equal to the 84th percentile for their 
reference age group, and had all relevant data needed to conduct the analyses. The SCT-
only group consisted of seven subjects who met or exceeded the 93rd percentile for their 
reference age group on the SCT subscale, had all relevant data needed to conduct the 
analyses, and either did not receive an ADHD diagnosis or received a diagnosis of Other 
Specified ADHD. This diagnosis is used by the adult ADHD outpatient specialty clinic to 
communicate that an individual has clinical levels of SCT symptomatology, but does not 
meet full criteria for an ADHD diagnosis. Means and standard deviations for each 
diagnostic group’s scores on the measures of internalizing symptoms and cognitive 
functioning are presented in Table 1. 
Demographic Analysis 
 The sample consisted of 93 males and 50 females. The mean age was 34.17, with 
a standard deviation of 12.69, a median age of 31, and an age range of 18 to 72. Subjects 
identified as 77.6% Caucasian, followed by 10.5% other, 3.5% African American, 3.5% 
Hispanic, and 2.8% Asian. Data on ethnicity was not available for three subjects. 
Subjects had a mean education level of 15.74 years, with a standard deviation of 2.21, 
and range of 11 to 21.    
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Table 1 
Internalizing Symptoms and Cognitive Functioning Across the Diagnostic Groups 
Diagnostic 













(n = 74) 
M 18.88 57.95 96.00 67.50 9.41 10.69 59.01 




(n = 36) 
M 14.64 50.06 90.47 59.39 9.81 10.19 56.72 
SD 8.69 14.43 12.28 12.02 2.66 2.66 10.23 
ADHD-only 
(n = 26) 
M 10.92 48.46 88.58 60.58 10.35 10.19 55.50 
SD 7.41 16.36 8.87 10.91 3.25 1.96 11.97 
SCT-only 
(n = 7) 
M 22.71 45.57 94.57 68.43 9.43 11.57 59.71 
SD 19.63 24.67 6.43 16.07 4.28 2.70 18.42 
Total sample 
(N = 143) 
M 16.55 53.63 93.19 64.24 9.68 10.52 57.83 
SD 10.91 15.76 8.67 12.79 2.95 2.75 12.21 
Note: BDI-II = Beck Depression Inventory-II; PSWQ = Penn State Worry Questionnaire; 
BDEFS Summary = Barkley Deficits in Executive Functioning Scale: Self Report - Total EF 
Summary % score; BADDS-Affect = Brown ADD Scales-Affect, T Score; Coding Task = 
WAIS-IV Digit Symbol Coding Scaled Score; Digit Span task = WAIS-IV Digit Span, Scaled 
Score; NEO-Neuroticism = NEO-Personality Inventory-Neuroticism-T Score. 
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Hypothesis 1 Analysis  
It was hypothesized that there would be a significant difference between subjects 
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD only, and SCT only, 
with those diagnosed with ADHD + SCT having higher levels of internalizing symptoms 
than the other groups. Internalizing symptoms were operationally defined as scores on the 
BDI-II, Penn State Worry Questionnaire (PSWQ), the affect subscale of the Brown 
Attention Deficit Disorder Scale-Adult Version (BADDS), and Neuroticism scale of the 
NEO-PI-R. 
A multiple analysis of variance (MANOVA) was conducted to examine whether 
subjects’ scores on the BDI-II, PSWQ, BADDS-Affect, and NEO-Neuroticism differed 
significantly between those who exhibited clinical levels of ADHD + SCT, ADHD + 
subclinical SCT, only SCT, and only ADHD. Diagnostic category served as the 
independent variable for this study.  
The assumptions of the MANOVA were tested by examining the normality, 
linearity, homoscedasticity, and multicollinearity of the data. To test the normality of the 
data, the skew and kurtosis of the data were calculated for the relevant variables. The 
skew and kurtosis of the variables used in these analyses were found to be within normal 
limits. Levene’s test was used to examine the homogeneity of the variance across the 
groups. The results of Levene’s test (Table 2) found the variance was unequal between 
the four diagnostic groups for subjects’ scores on the BDI-II, F(3, 139) = 5.409, p = 
0.002. The variance was also unequal for subjects’ scores on the PSWQ for the four 
diagnostic groups, F(3, 139) = 3.345, p = 0.021.  
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The variance-covariance ratio was tested using Box’s test of equality of 
covariance matrices. The Box’s M value of 55.468 was found to be not significant (p = 
0.02), indicating the assumptions of homogeneity covariance were met between the 
diagnostic groups. Due to unequal sample size, violation of the assumptions of equal 
variance, and groups differing along more than one variate, Pillai’s trace was used as the 
significance statistic because it is more robust than the other statistics to violations of 
model assumptions (Field, 2013; Olson, 1974). 
 
Table 2 
Levene’s Test of Equality of Error Variances in Measures of Internalizing Symptoms 
aDesign: Intercept + Diagnostic group 
 
Scores from the BADDS-Affect, BDI-II, PSWQ, and Neuroticism scale of the 
NEO-PI-R were tested for linearity and multicollinearity. As required for MANOVA, 
these dependent variables demonstrated significant correlations with one another, ranging 
from 0.244 to 0.517 (p < 0.01). These correlations are provided in Table 3. Bonferroni 
corrections were used to account for the potential of increased Type I experiment-wise 
 F df1 df2 p 
NEO-Personality Inventory-Neuroticism 2.382 3 139 .072 
Beck Depression Inventory-II 5.409 3 139 .002 
Penn State Worry Questionnaire 3.345 3 139 .021 
Brown ADD Scales-Affect, T Score 1.512 3 139 .214 
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error rate caused by conducting multiple statistical tests in this study. To correct for the 
experiment-wise error rate of three comparisons the critical p value was set at 0.01, with 
a desired power level of 0.80. Using Pillai’s trace, there was a significant effect of 
diagnostic group on subjects’ scores on the measures of internalizing symptoms, V = 
0.198, F(12, 414) = 2.439, p = .004. The observed power for this MANOVA was .897. 
Results from the multivariate tests are provided in Table 4.  
 
Table 3  
Summary of Pearson Correlations Between Measures of Internalizing Symptoms 
 NEO- Neuroticism BDI-II PSWQ BADDS-Affect 
NEO-Personality Inventory-
Neuroticism, T Score 
- .244** .409*** .328*** 
Beck Depression Inventory-II .244** - .255** . 517*** 
Penn State Worry Questionnaire .409*** .255** - .447*** 
Brown ADD Scales-Affect, T Score .328*** .517*** .447*** - 
Note: BDI-II = Beck Depression Inventory-II; PSWQ = Penn State Worry Questionnaire; 
BADDS-Affect = Brown ADD Scales-Affect, T Score; NEO-Neuroticism = NEO-
Personality Inventory-Neuroticism-T Score. 
**p < .01 one-tailed, ***p < .001 one-tailed 
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Table 4 
Multivariate Tests for Differences in Internalizing Symptoms Between Groupsa 







Pillai’s Trace .953 691.63b 4 13 .000 .953 2766.53 1.00 
Wilks’ Lambda .047 691.63b 4 136 .000 .953 2766.53 1.00 
Hotelling’s Trace 20.342 691.63b 4 136 .000 .953 2766.53 1.00 
Roy’s Largest 
Root 
20.342 691.63b 4 136 .000 .953 2766.53 1.00 
Diagnostic group         
Pillai’s Trace .198 2.44 12 414 .004 .066 29.26 .897 
Wilks’ Lambda .812 2.46 12 360.11 .004 .067 25.90 .943 
Hotelling’s Trace .220 2.46 12 404 .004 .068 29.57 .971 
Roy’s Largest 
Root 
.146 5.026c 4 138 .001 .127 20.11 .959 
Note. Hyp. df = Hypothesis degrees of freedom 
aDesign: Intercept + Diagnostic group 
bExact statistic 
cThe statistic is an upper bound on F that yields a lower bound on the significance level. 
dComputed using α = .01 
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A univariate ANOVA revealed subjects’ NEO-Neuroticism scores did not differ 
significantly between the diagnostic groups, F(3, 139) = 0.698, p = 0.555. Separate 
univariate ANOVAs also revealed significant effects of diagnostic group on the BDI-II, 
F(3, 139) = 4.914, p = 0.003; PSWQ, F(3, 139) = 4.286, p = 0.006; and BADDS-Affect, 
F(3, 139) = 4.617, p = 0.004. The observed power for these univariate ANOVAs ranged 
from 0.068 to 0.751. The results of these univariate ANOVAs are provided in Table 5. 
 
Table 5 
Univariate Analysis of Variance Tests Comparing Between-Groups Effects for 
Internalizing Symptoms 







313.835a 3 104.61 .698 .555 .068 
 
 BDI-II 1621.871b 3 540.62 4.914** .003 .751 
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 Dependent 





239602.529 1 239602.53 1598.260*** .000 1.000 
BDI-II 20258.501 1 20258.50 184.126*** .000 1.000 
PSWQ 183360.727 1 183360.73 789.177*** .000 1.000 
BADDS-
Affect 





313.835 3 104.61 .698 .555 .068 
 
BDI-II 1621.871 3 540.62 4.914*** .003 .751 








20838.137 139 149.92 
   
BDI-II 15293.486 139 110.03    
PSWQ 32295.848 139 232.34    
BADDS-
Affect 
21127.116 139 151.99 
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 Dependent 






    
BDI-II 56095 143     










    
BDI-II 16915.357 142     




    
Note. BDI-II = Beck Depression Inventory-II; PSWQ = Penn State Worry Questionnaire; 
BADDS-Affect = Brown ADD Scales-Affect, T Score; NEO-Neuroticism = NEO-Personality 
Inventory-Neuroticism-T Score. 
aR2 = .015, bR2 = .096, cR2 = .085, dR2= .091 
*p < .05, **p < .01, ***p < .001 
 
 The results of these post hoc ANOVAs should be interpreted with caution 
regarding the BDI-II and PSWQ, due to significant findings from Levene’s test. Field 
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admits that he includes the Levene’s test in his book out of expectation from others only. 
Field points out that Levene’s test can be statistically significant in larger samples, in 
which there are small effects that have less practical significance. Field reports that many 
statisticians have discontinued using the test, specifically for two reasons, one of which is 
relevant in the present context. Of importance, Levene’s test is less practical with larger 
sample sizes and when groups are not equal. This is precisely the case in the present 
instance. Although there are many ways of adjusting the data to resolve differences in 
variances, there is controversy about doing so as well. Field (2018) recommends using 
robust statistical analysis as the best alternative. 
 In line with Field (2018), because there were significant differences in variances 
between the diagnostic groups for the BDI-II and PSWQ, robust tests of equality of 
means were performed in each instance. Although the original post hoc ANOVAs 
between groups were significant for the BDI-II (p =.003) and PSWQ (p = .006), the 
results from performing a Brown-Forsythe were not significant. For the BDI-II the 
Brown-Forsythe statistic (3, 12.295) = 3.077, p = .067. For the PSWQ the Brown-
Forsythe statistic (3, 18.841) = 2.844, p = .065. By using this more robust statistic, in 
each instance the results went from being statistically significant to approaching 
significance only. For these reasons post hoc testing with the Tukey was not performed 
on the BDI-II and PSWQ.  
Post hoc comparisons using the Tukey HSD indicated that the mean score for the 
ADHD + SCT group on the BADDS-Affect scale was significantly higher than the mean 
BADDS-AFFECT score of those in the ADHD + subclinical SCT group (p < .01). The 
results of these post hoc analyses are provided in Table 6. It is important to note that the 
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group sizes used in these analyses are unequal. The harmonic mean of the group sizes is 
used, Type I error levels may be inaccurate.  
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Table 6 


















ADHD + SCT ADHD + 
subclinical SCT 
8.11** 2.505 .008 1.60 14.63 
ADHD-only 6.92 2.811 .070 -.39 14.23 
SCT-only -.93 4.875 .998 -13.61 11.75 
ADHD + 
subclinical SCT 
ADHD + SCT -8.11** 2.505 .008 -14.63 -1.60 
ADHD-only -1.19 3.173 .982 -9.44 7.06 
SCT-only -9.04 5.093 .290 -22.28 4.20 
ADHD-only ADHD + SCT -6.92 2.811 .070 -14.23 .39 
ADHD + 
subclinical SCT 
1.19 3.173 .982 -7.06 9.44 
SCT-only -7.85 5.250 .443 -21.50 5.80 
SCT-only ADHD + SCT .93 4.875 .998 -11.75 13.61 
ADHD + 
subclinical SCT 
9.04 5.093 .290 -4.20 22.28 
ADHD-only 7.85 5.250 .443 -5.80 21.50 
Note. The error term is MS (Error) = 151.994. 
**p < .01 
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Hypothesis 2 Analysis  
It was hypothesized that there would be a significant difference between subjects 
diagnosed with ADHD + SCT, ADHD + subclinical SCT, ADHD-only, and SCT only, 
with those diagnosed with ADHD + SCT exhibiting significantly more impaired 
cognitive functioning than all other groups. Impaired cognitive functioning was 
operationally defined as standardized scores from the Coding task and Digit Span task, as 
well as the BDEFS Summary score, A MANOVA was conducted to determine if the 
scores on the measures of cognitive functioning significantly differed between subjects 
who exhibited ADHD + SCT, ADHD + subclinical SCT, SCT only, or ADHD-only.  
To correct for the experiment-wise error rate of three comparisons, the critical p 
value was set at 0.01. An a priori power analysis determined that a sample size of 120 
would be required to achieve the minimal power level of 0.8 with p = 0.01, four groups, 
and three dependent variables. Of the total sample of 143 subjects, there were 74 in the 
ADHD + SCT group, 36 in the ADHD + subclinical SCT group, 24 in the ADHD-only 
group, and seven in the SCT-only group.  
Tests of normality revealed a negative skew (-3.138) and a leptokurtic distribution 
(12.022) for subjects’ BDEFS Summary score. Skew and kurtosis were within normal 
limits for subjects’ scores on the Coding task and Digit Span task. Although the 
distribution of subjects’ BDEFS Summary scores violates the assumptions of normalcy, 
this distribution makes sense because this is a clinical sample of individuals with ADHD, 
SCT, or both. These diagnoses are associated with difficulties in executive functioning. 
The variance-covariance ratio was tested using Box’s test of equality of covariance 
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matrices. Box’s M was calculated to be 13.316 and was found to be not significant 
(p =.187), indicating the assumptions of equal variance were met.  
Scores from the Coding task, Digit Span task, and BDEFS Summary were tested 
for linearity and multicollinearity. As shown in Table 7, none of these variables were 
correlated at the critical significance level (p > .01). As per the MANOVA, there were no 
significant effects of diagnostic group on subjects’ scores on the measures of cognitive 
functioning. Specifically, using Pillai’s trace there was not a significant effect of the 
diagnostic group on measures of cognitive functioning, V = .035, F(6, 278) = .828, p = 
.55. Using Wilks’ lambda, there was not a significant effect of the diagnostic group on 
measures of cognitive functioning, Λ = .965, F(6, 276) = .827, p = .55. Using Hotelling’s 
trace statistic, there was not a significant effect of the diagnostic group on measures of 
cognitive functioning, T = .036, F(6, 276), = .824, p = .55. Using Roy’s largest root test, 
there was not a significant effect of the diagnostic group on measures of cognitive 
functioning, Θ = .033 F(3, 139) = 1.511, p = .214. The measures of cognitive functioning 
examined did not significantly differ between subjects who exhibited varied levels of 
ADHD and SCT symptomatology in this analysis. Therefore, univariate tests of between 
subjects’ effects were not interpretable.  
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Table 7 
Correlations Between Measures of Cognitive Functioning 
 
BDEFS 
Summary Coding task Digit Span task 
Barkley Deficits in Executive Functioning 
Scale: Self Report - Total EF Summary  
- -.081 .146* 
WAIS-IV Digit Symbol Coding, Scaled 
Score 
-.081 - .184* 
WAIS-IV Digit Span, Scaled Score   .146*   .184* - 
Note. BDEFS Summary = Barkley Deficits in Executive Functioning Scale: Self Report - 
Total EF Summary. Coding task = WAIS-IV Digit Symbol Coding, Scaled Score. Digit 
Span task = WAIS-IV Digit Span, Scaled Score.  
*p < .05 1-tailed 
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Table 8 
Multivariate Tests for Differences in Cognitive Functioning Between Groupsa 







Pillai’s Trace .918 769.097b 2 138 .00 .918 1538.194 1.000 
Wilks’ Lambda .082 769.097b 2 138 .00 .918 1538.194 1.000 
Hotelling’s Trace 11.146 769.097b 2 138 .00 .918 1538.194 1.000 
Roy’s Largest 
Root 
11.146 769.097b 2 138 .00 .918 1538.194 1.000 
Diagnostic group         
Pillai’s Trace .035 .828 6 278 .55 .018 4.970 .327 
Wilks’ Lambda .965 .827b 6 276 .55 .018 4.963 .326 
Hotelling’s Trace .036 .826 6 274 .55 .018 4.956 .326 
Roy’s Largest 
Root 
.033 1.511c 3 139 .21 .032 4.534 .392 
Note. Hyp. df  = Hypothesis degrees of freedom 
aDesign: Intercept + Diagnostic group 
bExact statistic 
cThe statistic is an upper bound on F that yields a lower bound on the significance level. 
dComputed using α = .05 
 
ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO         78 
Hypothesis 3 Analysis 
It was hypothesized that anxiety and deficits in executive functioning would 
predict SCT after accounting for ADHD symptomatology. SCT was operationally 
defined as subjects’ percentile rank on the BAARS-IV SCT subscale (SCT Percentile 
Rank). Anxiety was operationalized as subjects’ scores on the PSWQ. Executive 
functioning was operationalized as subjects’ BDEFS Summary score. ADHD 
symptomatology was operationally defined as subjects’ scores on the DSM-IV Inattentive 
symptoms and DSM-IV Hyperactive/Impulsive symptoms scales of the CAARS.  
A regression analysis was conducted to examine the associations between 
internalizing symptoms (operationalized as scores on the BDI-II, PSWQ, BADDS-Affect, 
and NEO-Neuroticism) and cognitive functioning (operationalized as BDEFS Summary, 
Digit Span task, and Coding Task) on the one hand, and SCT symptomatology, on the 
other hand. The normality, homoscedasticity, linearity, and multicollinearity of the data 
were examined to test the assumptions of this regression analysis. To test the normality of 
the data, a frequencies distribution calculated the skew and kurtosis of the data. Subjects’ 
SCT Percentile Ranks were found to be negatively skewed (-2.317) and leptokurtic 
(6.939). Subjects’ BDEFS Summary scores were negatively skewed  
(-3.128) and leptokurtic (12.022). Bonferroni corrections were used to account for the 
increased Type I experiment-wise error rate caused by conducting multiple statistical 
tests on the same data set. To correct for the experiment-wise error rate of three 
comparisons, the critical p value was set at 0.01.  
 
  
ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO         79 
Table 9 
Summary of Pearson Correlations Between Measures of SCT, Internalizing Symptoms, 
and Cognitive Functioning 
Measure 1 2 3 4 5 6 7 8 9 
1. SCT Percentile 
Rank 




.11 - .04 .00 .01 .05 .01 -.09 .07 
3. CAARS 
Hyperactive/Impul
sive T Score 
.05 .04 - .02 .04 -.01 -.16 -.07 .15* 
4. Beck Depression 
Inventory-II 
.33** .00 .02 - .02 .52** -.08 -.13 .24** 
5. Penn State Worry 
Questionnaire 
.23** .01 .04 .02 - .45** -.12 .04 .42** 
6. Brown ADD 
Scales-Affect, T 
Score 
.28** .05 -.01 .52** .45** - -.03 -.06 .35** 
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Measure 1 2 3 4 5 6 7 8 9 
7. WAIS-IV Coding 
Task, Scaled 
Score 
-.14* .01 -.16* -.08 -.12 -.03 - .18* -.08 





-.07 -.13 .04 -.06 .18* - .15* 
9. Barkley Deficits in 
Executive 
Functioning Scale: 
Self Report - Total 
EF Summary  
.46** .07 .15* .24** .42** .35** -.08 .15* - 
Note. 1 = Barkley Adult ADHD Rating Scale: Self report Current Symptoms - sluggish 
cognitive tempo, Percentile Rank; 2 = Conners Adult ADHD Rating Scales-Inattentive 
Symptoms, T Score; 3 = Conners Adult ADHD Rating Scales-Hyperactive-Impulsive 
Symptoms, T Score; 4 = Beck Depression Inventory-II; 5 = Penn State Worry 
Questionnaire; 6 = Brown ADD Scales-Affect, T Score; 7 = WAIS-IV Digit Symbol 
Coding, Scaled Score; 8 = WAIS-IV Digit Span Task, Scaled Score. 
 *p < .05 one-tailed, **p < .01 one-tailed 
 
The association between scores on the measures of cognitive processing and 
internalizing symptoms were examined using Pearson product-moment correlations to 
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determine which variables were to be retained for regression analysis. There was no 
significant relationship found between SCT Percentile Rank and scores on the CAARS 
inattentive subscale, r = .111, p = .093; or between SCT Percentile Rank and scores on 
the CAARS hyperactive/impulsive subscale, r = .049. p =.280. SCT Percentile Rank also 
did not evince a significant relationship with performance on the Digit Span task, r = 
.066, p = .217. Subjects’ scores on the BDI-II, PSWQ, BADDS-Affect, Coding task, and 
BDEFS Summary all demonstrated significant Pearson product-moment correlations with 
SCT Percentile Rank (See Table 9 for details of the correlational matrix). There was a 
significant relationship between BDI-II scores and SCT Percentile Rank, r = .329, p < 
.001. There was also a significant relationship between PSWQ scores and SCT Percentile 
Rank, r = .225, p = .003. Scores from the BADDS-Affect scale were significantly related 
to SCT Percentile Rank, r = .277, p = .000. In addition, there was a significant 
relationship between Coding Task scores and SCT Percentile Rank, r = -.138, p = .050. 
Finally, there was a significant relationship between BDEFS Summary scores and SCT 
Percentile Rank, r = .463, p < .001.  
Original statistical regression plan for hypothesis 3. The original statistical 
regression plan, which was not used in this study, was to enter the CAARS Inattentive 
and CAARS Hyperactive/Impulsive symptom scales into regression model 1 as the only 
predictor variables for SCT Percentile Rank. This would have been intended to examine 
the relationship between ADHD symptomatology and SCT and to account for the strong 
relationship between ADHD and SCT seen in previous research.  
Regression model 2 would have retained the CAARS scores and added relevant 
scores from the measures of internalizing symptoms (BDI-II, PSWQ, and BADDS-
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Affect) and cognitive functioning (BDEFS Summary score and the Coding task) as 
predictor variables for SCT Percentile Rank. Howeverbecause neither of the CAARS 
scores was correlated with the dependent variable in these analyses, there was no need to 
ensure they were entered hierarchically as the first predictors into the model. Therefore, 
all five remaining predictors were entered into the regression model using the forced 
entry method.  
Statistical regression testing hypothesis 3. The regression model used in this 
study, including the BDI-II, PSWQ, BADDS-Affect, BDEFS Summary, and Coding 
Task as predictors, was found to predict a significant portion of the variance in SCT 
Percentile Rank scores (R = .523; R2 = .274, p < .001). The Durbin-Watson test found the 
autocorrelation of the model’s residuals was within an acceptable range (1.042). The 
adjusted coefficient of determination indicates shrinkage of only 2.6% (Adjusted R2 = 
.248) if this model was generalized to the population of adults with either ADHD or SCT. 
Details of the model summary can be found in Table 10. 
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Table 10 
Regression Model Summary Utilizing Measures of Internalizing Symptoms and Cognitive 














.523a .274 .248 9.67217 .274 10.343 5 137 .000 1.042 
aPredictors: (Constant), Barkley Deficits in Executive Functioning Scale: Self Report – 
Total EF Summary, WAIS-IV Digit Symbol Coding Scaled Score, Beck Depression 
Inventory-II, Penn State Worry Questionnaire, Brown ADD Scales-Affect T Score 
 
As shown in Table 11, the overall regression analysis was significant, indicating 
the regression model predicted SCT Percentile Ranks significantly better than chance, 
F(5,137) = 10.34, p <.001. Two of the predictor variables were found to significantly 
contribute to the regression model. Scores on the BDI-II significantly predicted SCT 
Percentile Rank, β = .215, t(137) = 2.514. p = .013. Additionally, BDEFS Summary 
scores significantly predicted SCT percentile, β = .403, t(137) = 4.921, p < .001. Other 
predictor variables were not significantly associated with SCT Percentile Rank in the 
regression model. Tolerance and Variance Inflation Factor for all predictor variables were 
normal, indicating no significant multicollinearity. Detailed statistics for each predictor 
variable can be found in Table 12. 
 
  
ADULTS WITH ADHD AND SLUGGISH COGNITIVE TEMPO         84 
Table 11  
Overall Regression Analysis With Predictor Variables to Subjects’ SCT Percentile 
Ranksa 
Model 1 SS df MS F p 
Regression   4837.768 5 967.554 10.343*** .000b 
Residual 12816.469 137 93.551   
Total 17654.237 142    
aDependent Variable: Barkley Adult ADHD Rating Scale: Self report Current Symptoms 
- sluggish cognitive tempo, Percentile based on age and raw score.  
bPredictors: (Constant), Barkley Deficits in Executive Functioning Scale: Self Report - 
Total EF Summary, WAIS-IV Digit Symbol Coding Scaled Score, Beck Depression 
Inventory-II, Penn State Worry Questionnaire, Brown ADD Scales-Affect T Score.  
***p < .001 
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Table 12  









B SE β Tolerance VIF 
 (Constant) 40.845 9.603  4.253 .000   
Beck Depression  
Inventory II 
.220 .087 .215* 2.514 .013 .724 1.380 
Penn State Worry 
Questionnaire 
-.016 .061 -.023 -.262 .794 .716 1.397 
Brown ADD Scales-Affect, T 
Score 
.029 .081 .033 .355 .723 .609 1.642 
WAIS-IV Digit Symbol 
Coding, Scaled Score 
-.339 .278 -.090 -1.219 .225 .977 1.023 
Barkley Deficits in Executive 
Functioning Scale: Self 
Report - Total EF Summary 
.518 .105 .403*** 4.921 .000 .790 1.266 
Note. VIF = Variance Inflation Factor 
aDependent Variable is Barkley Adult ADHD Rating Scale: Self report Current 
Symptoms - sluggish cognitive tempo, Percentile based on age and raw score 
 *p < .05, ***p < .001 
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Exploratory Analyses 
Two exploratory analyses were conducted and are explored below.  
Diagnostic group differences in executive functioning 
A one-way ANOVA was conducted to explore whether subjects from the 
diagnostic groups, differed significantly in executive functioning, operationalized as 
BDEFS Summary scores. To correct for the experiment-wise error rate, the critical p 
value was set at .01. As previously mentioned, tests of normality revealed a negative 
skew (-3.138) and a leptokurtic distribution (12.022) for BDEFS Summary scores. This 
violates the assumption of normality of the data for the ANOVA.  
Results of the one-way ANOVA found there was a significant difference between 
the four diagnostic groups on BDEFS Summary scores, F(3,139) = 7.08, p <.001. A 
Bonferroni corrected post hoc revealed subjects with ADHD + SCT had significantly 
higher mean BDEFS Summary scores than the ADHD + subclinical SCT subjects, p = 
.007, d = 5.53. Significant differences were also noted between ADHD + SCT subjects’ 
higher mean BDEFS Summary scores compared to the ADHD-only subjects, p = .001, d 
= 7.42. No significant differences were found between the seven subjects with SCT only 
and the other diagnostic groups and no significant differences were found between the 
ADHD + subclinical SCT groups’ mean BDEFS Summary scores and the mean scores of 
the SCT-only or ADHD-only groups. A post hoc Tukey HSD test found the same pattern 
of significant findings. Results of the post hoc tests are provided in Table 13 and Table 
14. This exploratory analysis implies that executive functioning measures may be the best 
indicators of the kinds of cognitive functioning issues that differentiate ADHD and SCT 
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symptomatology, as opposed to tests like the Coding and Digit Span tasks from the 
WAIS-IV in adults with ADHD + SCT.  
 
Table 13 
Results of One-Way Analysis of Variance Examining Diagnostic Group Influence on 
Subjects’ BDEFS Scores 
 SS df MS F p 
Between Groups 1416.869 3 472.290 7.084*** .000 
Within Groups 9267.033 139 66.669   
Total 10683.902 142    
***p < .001 
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Table 14 
Post Hoc Tukey’s HSD and Bonferroni Tests Examining Difference Between Diagnostic 

















5.528** 1.659 .006 1.21 9.84 
ADHD-only 7.423** 1.861 .001 2.58 12.26 




ADHD + SCT -5.528* 1.659 .006 -9.84 -1.21 
ADHD-only 1.895 2.101 .804 -3.57 7.36 
SCT-only -4.099 3.373 .618 -12.87 4.67 
ADHD-
only 
ADHD + SCT -7.423* 1.861 .001 -12.26 -2.58 
ADHD + 
subclinical SCT 
-1.895 2.101 .804 -7.36 3.57 
SCT-only -5.995 3.477 .315 -15.04 3.05 
SCT-only ADHD + SCT -1.429 3.229 .971 -9.82 6.97 
ADHD + 
subclinical SCT 
4.099 3.373 .618 -4.67 12.87 
ADHD-only 5.995 3.477 .315 -3.05 15.04 
 
  


















5.528** 1.659 .007 1.09 9.97 
ADHD-only 7.423** 1.861 .001 2.44 12.41 




ADHD + SCT -5.528** 1.659 .007 -9.97 -1.09 
ADHD-only 1.895 2.101 1.00 -3.73 7.52 
SCT-only -4.099 3.373 1.00 -13.13 4.93 
ADHD-
only 
ADHD + SCT -7.423** 1.861 .001 -12.41 -2.44 
ADHD + 
subclinical SCT 
-1.895 2.101 1.00 -7.52 3.73 
SCT-only -5.995 3.477 .521 -15.30 3.31 
SCT-only ADHD + SCT -1.429 3.229 1.00 -10.07 7.21 
ADHD + 
subclinical SCT 
4.099 3.373 1.00 -4.93 13.13 
ADHD-only 5.995 3.477 .521 -3.31 15.30 
*p < .05 **p < .01. 
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The impact of SCT in adults with ADHD on internalizing disorders and 
cognitive functioning. An additional exploratory MANOVA was conducted to examine 
whether the degree of internalizing symptoms and cognitive functioning varied in adults 
with ADHD who have differing levels of SCT. Diagnostic groups served as the 
independent variable in this analysis. The measures of internalizing symptoms and 
cognitive functioning that were found to significantly differ between diagnostic groups 
across the previous analyses in this study served as the dependent variables. The seven 
subjects with SCT only were not included in these analyses because they did not exhibit 
clinically significant levels of ADHD.  
Previous analyses found subjects’ BDEFS Summary scores were positively 
skewed and leptokurtic, with a skew of 3.128 (SE = 0.203) and kurtosis of 12.022 (SE = 
0.403). Box’s test found that the assumptions of homogeneity of covariance were not met 
between the diagnostic groups. The value of Box’s M was calculated as 95.388 and was 
found to be significant (p < .001).  
Levene’s test indicated that the homogeneity of variance across groups was 
unequal. As indicated in Table 15, the variance in subjects scores was unequal between 
the three diagnostic groups on the BDI-II, F(2, 133) = 6.295, p = 0.002; Digit Span task, 
F(2, 133) = 5.066, p = .008; and BDEFS Summary scores, F(2, 133) = 6.283, p = 0.002.  
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Table 15 
Levene’s Test of Equality of Error Variances for Measures of Internalizing Symptoms 
and Cognitive Functioning 




.983 2 133 .377 
Beck Depression 
Inventory-II 
6.295** 2 133 .002 
Penn State Worry 
Questionnaire 
1.387 2 133 .253 
Brown ADD Scales-
Affect, T Score 
.901 2 133 .409 
WAIS-IV Digit Span, 
Scaled Score 
5.066** 2 133 .008 
Barkley Deficits in 
Executive Functioning 
Scale: Self Report - 
Total EF Summary (1-
5), % score 
6.283** 2 133 .002 
Note. Design = Intercept + Diagnostic Group 
** p < .01 
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Due to unequal sample sizes, groups differing along more than one variate, 
violations of normalcy of the data, and the assumptions of equal covariance; Pillai’s trace 
was used as the significance statistic in the MANOVA because it is more robust than the 
other statistics and more appropriate for violations of model assumptions (Olson, 1974; 
Field, 2013). Pillai’s trace indicated a significant overall effect of diagnostic group on 
measures of the following internalizing symptoms and cognitive processing, BDI-II, 
PSWQ, BADDS-Affect, and BDEFS Summary, V = 0.225, F(12. 258) = 2.720, p = 
0.002. The observed power for this analysis was 0.982. Details of the MANOVA are 
presented in Table 16.  
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Table 16 
Multivariate Tests for Differences in Internalizing Symptoms and Cognitive Functioning 
Between Adults with ADHD and Varying Levels of SCTa 







Pillai’s Trace .992 2672.558b 6 128 .000 .992 16035.346 1.000 
Wilks’ Lambda .008 2672.558b 6 128 .000 .992 16035.346 1.000 
Hotelling’s Trace 125.276 2672.558b 6 128 .000 .992 16035.346 1.000 
Roy’s Largest 
Root 
125.276 2672.558b 6 128 .000 .992 16035.346 1.000 
Diagnostic group         
Pillai’s Trace .225 2.720 12 258 .002 .112 32.643 .982 
Wilks’ Lambda .781 2.810b 12 256 .001 .116 33.715 .986 
Hotelling’s Trace .274 2.898 12 254 .001 .120 34.772 .988 
Roy’s Largest 
Root 
.246 5.278c 6 129 .000 .197 31.670 .994 
Note. Hyp. df  = Hypothesis degrees of freedom 
aDesign: Intercept + Diagnostic group 
bExact statistic 
cThe statistic is an upper bound on F that yields a lower bound on the significance level. 
dComputed using α = .05 
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As determined by univariate ANOVA, diagnostic group had a significant effect 
on BDI-II, F(2, 133) = 6.876, p = 0.001; PSWQ, F(2,133) = 5.286, p = 0.004; BADDS-
Affect scale, F(2, 133) = 6.714, p = 0.002; and BDEFS Summary score, F(2, 133) = 
10.343, p < 0.001. However, the following were not significant: the effect of diagnostic 
group on NEO-Neuroticism, F(2, 133) = 1.018, p = 0.364, and the Digit Span task, F(2, 
133) = 0.543, p = 0.582. Results from the univariate ANOVAs are provided in Table 17.  
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Table 17 
Discriminant Analyses of Variance Examining Between-Subjects Effects of Diagnostic 
Group on Dependent Variables 





287.762 2 143.881 1.018 .364 .225 
Beck Depression 
Inventory-II 
1342.413 2 671.207 6.876** .001 .917 
Penn State Worry 
Questionnaire 
2509.601 2 1254.801 5.826** .004 .865 
Brown ADD Scales-
Affect, T Score 
1976.481 2 988.240 6.714** .002 .911 
WAIS-IV Digit Span, 
Scaled Score 
8.287 2 4.144 .543 .582 .138 
Barkley Deficits in 
Executive 
Functioning Scale: 
Self Report - Total 
EF Summary 
1402.799 2 701.400 10.343*** .000 .986 
**p < .01 ***p < .001 
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Levene’s test indicated the variance was unequal between the three diagnostic 
groups on the BDI-II, Digit Span task, and BDEFS Summary scores. Since there were 
significant differences in variances between the diagnostic groups for the BDI-II, Digit 
Span task, and BDEFS summary scores, robust tests of equality of means were performed 
in each instance. Brown-Forsythe’s test indicated that the homogeneity of variance across 
groups was unequal between the three diagnostic groups on the BDI-II (2, 115.844) = 
8.611, p < .001 and BDEFS Summary score (2, 66.89) = 7.558, p = .001. The assumption 
of homogeneity of variance was met between the groups on the Digit Span task (2, 
111.652) = .663, p = .517. 
The pattern of the results was the same for the original post hoc discriminant 
ANOVAs and the ANOVAs utilizing the Brown-Forsythe statistic. As determined by 
univariate ANOVA using the Brown-Forsythe as the F statistic, diagnostic group had a 
significant effect on BDI-II, F(2, 133) = 6.876, p = 0.001; and BDEFS Summary score, 
F(2, 133) = 10.343, p < 0.001. The effect of diagnostic group on the Digit Span task was 
not significant, F(2, 133) = 0.543, p = 0.582.  
Due to unequal homogeneity of variance, the Games Howell test was used for 
post hoc comparisons of group means. The test compares the difference between each 
pair of means with appropriate adjustment for the multiple testing. Because the Games 
Howell post-hoc test does not assume homogeneity of variances or equal sample sizes, it 
is a more robust statistic when the assumption of homogeneity of variances is violated 
(Ruxton & Beauchamp, 2008). 
Post-hoc comparisons using the Games Howell statistic indicated that the mean 
BDI-II score of those in the ADHD + SCT group was significantly higher than those in 
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the ADHD-only group (p = 0.002). The ADHD + SCT group’s mean PSWQ score was 
significantly higher than both the ADHD + subclinical SCT group (p = 0.023) and the 
ADHD-only group (p = 0.032). The ADHD + SCT group exhibited a significantly higher 
mean score on the BADDS-Affect scale than the ADHD+ subclinical SCT (p = 0.005) 
and ADHD-only group (p = 0.027). The ADHD + SCT group had a significantly higher 
mean BDEFS Summary score than the ADHD + subclinical group (p = 0.003) and the 
ADHD-only group (p < 0.001). The three groups investigated in this analysis did not 
have significant differences between their mean scores on NEO-Neuroticism or the Digit 
Span task. Detailed results of these post hoc tests are provided in the appendix. As with 
previous analyses, the unequal group sizes may impact the accuracy of Type 1 error 
levels in these analyses.  
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Chapter 5: Discussion 
The results of the current study indicate that there are significant differences 
between those diagnosed with ADHD + SCT, ADHD + subclinical SCT, and ADHD 
only on many of the examined measures of internalizing symptoms and cognitive 
functioning. Subjects’ scores on measures of depression, worry, affect regulation, and 
executive dysfunction were found to be higher amongst the subjects diagnosed with 
ADHD + SCT, than those with ADHD only, or those with ADHD and subthreshold 
levels of SCT, in many analyses. The handful of subjects in the SCT-only group did not 
significantly differ from other groups on these measures. Measures of cognitive 
processing speed, auditory working memory, and neuroticism did not differ between 
groups.  
 The results of the analyses partially supported the first hypothesis that there would 
be significant differences between the four diagnostic groups on measures of 
internalizing symptoms. Similar to previous studies examining internalizing symptoms in 
individuals with varying levels of ADHD and SCT symptomatology, the ADHD + SCT 
group exhibited significantly higher mean scores on a self-report measure of affect 
regulation than the ADHD + subclinical SCT group. Notably, these differences were not 
evident in all of the diagnostic groups, in this or previous studies (Carlson & Mann, 2002; 
Kamradt et al., 2018). On the other hand, the diagnostic groups did not differ on 
measures of depression, anxiety, or neuroticism.   
Findings from this study did not support the second hypothesis, which posited 
diagnostic groups would significantly differ on measures of cognitive functioning, which 
was operationalized as measures of executive functioning, cognitive processing speed, 
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and auditory working memory. None of these variables were found to significantly differ 
between the diagnostic groups. Previous research produced mixed results in terms of 
significance and effect size when investigating the relationship between SCT and 
measures of executive functioning (Barkley, 2012; Bauermeister et al., 2012; Jarrett et 
al., 2017; Leikauf and Solanto, 2017), as well as SCT and measures of 
neuropsychological functioning (Jacobsen et al., 2018; Bauermeister et al., 2012). This 
pattern of inconsistent findings in the literature and this study may be attributable to 
diffuse deficits in cognitive functioning for those with ADHD and SCT, rather than 
exhibiting discrete and easily identifiable areas of impairment (Hervey et al., 2014; 
Mapou, 2019). This pattern of results in our sample may have been related to a relatively 
higher level of functioning in this sample, as compared to the general adult ADHD 
population (more on this below). 
This study also found symptoms of impaired executive functioning and 
depression significantly predicted SCT symptomatology in adults who exhibit clinical 
levels of ADHD or SCT symptoms. This was partially consistent with the third 
hypothesis, which further predicted anxiety and executive functioning would be 
associated with SCT, after accounting for ADHD symptomatology. These findings are 
consistent with previous lines of research that have shown SCT symptomatology 
significantly contributes to the variance in internalizing symptomatology, above and 
beyond the contributions of ADHD symptoms (Becker, Langberg, et al., 2014). 
Depression may be a better predictor of SCT symptomatology than anxiety, not just due 
to similarities in their symptom presentations, but from common underlying symptoms, 
which overlap with feeling tired and lethargic, being in a fog, being underactive or slow 
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moving, and feeling apathetic or unmotivated in SCT (Becker, Marshall, & McBurnett, 
2014). 
 Interestingly, ADHD symptomatology was not associated with SCT 
symptomatology in this sample, which is directly contrary to the well-established 
relationship between inattentive symptoms of ADHD and SCT symptomatology 
(Barkley, 2011a, 2012; Becker & Barkley, 2018; Becker et al., 2016; Garner et al., 2010; 
Leikauf & Solanto, 2017; Lunsford-Avery et al., 2018; Wåhlstedt & Bohlin, 2010). 
Nonetheless, this finding is consistent with prior research demonstrating inattentive, 
hyperactive/impulsive, and SCT symptoms are unique from one another and represent 
unique symptom domains that frequently occur together (Bauermeister et al., 2012; 
Becker, Marshall, & McBurnett, 2014; Neeper & Lahey, 1986). 
Interpretations and Implications 
Differences in Internalizing Symptoms Between Diagnostic Groups  
The current study explored the differences in internalizing symptoms; such as 
anxiety, depression, affect regulation, and neuroticism; between individuals with varying 
levels of ADHD and SCT symptomatology. The results of the analyses were partially 
consistent with the first hypothesis’ prediction that there would be a significant difference 
between subjects across the diagnostic groups, with those diagnosed with ADHD + SCT 
having higher levels of internalizing symptoms than the other diagnostic groups. The first 
hypothesis was not supported, in that individuals who exhibited clinical levels of both 
ADHD and SCT symptomatology only differed from one other group on one measure of 
internalizing symptoms in this study. Those with both clinical ADHD and SCT 
symptomatology did not report higher levels of depression than subjects with other 
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presentations of ADHD and SCT. Depression was operationalized as scores on the BDI-
II. Although the original post hoc comparison was significant, the use of more robust post 
hoc tests found the differences between diagnostic groups’ depression levels were not 
significant, but did approach significance. This is inconsistent with many previous studies 
that found relationships between SCT symptoms and depressive symptoms after 
controlling for ADHD symptoms. Furthermore, previous studies show individuals with 
higher levels of SCT exhibit more depressive symptoms than those with lower levels of 
SCT (Becker & Barkley, 2018; Bauermeister et al., 2012; Carlson & Mann, 2002; 
Kamradt et al., 2018; Leikauf & Solanto, 2017). However, in the exploratory MANOVA 
including both relevant internalizing symptoms and cognitive functioning, the ADHD + 
SCT subjects were found to have higher levels of depression, than those with ADHD and 
subclinical or negligent levels of SCT. 
 Subjects with ADHD + SCT did not endorse greater frequency and intensity of 
anxiety than the other diagnostic groups. Anxiety was operationalized as scores on the 
PSWQ. Again, although the original post hoc comparison of diagnostic groups’ anxiety 
levels was significant, the use of robust post hoc tests found the between groups 
differences were not significant. This is inconsistent with previous research findings that 
higher levels of SCT are associated with greater intensity and frequency of anxiety 
symptoms (Bauermeister et al., 2012; Carlson & Mann, 2002; Kamradt et al., 2018; 
Leikauf & Solanto, 2017). The exploratory MANOVA including relevant internalizing 
symptoms and cognitive functioning found the ADHD + SCT subjects reported higher 
levels of anxiety than those with ADHD and subclinical or negligent levels of SCT 
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 The subjects’ ability to manage affect and emotion that could interfere with work 
was also investigated and was operationalized as scores on the affect scale of the 
BADDS. Subjects with both ADHD + SCT evidenced greater difficulty with affect 
regulation than those with ADHD + subclinical SCT. Affect regulation did not 
significantly differ between ADHD + SCT and ADHD-only subjects. However, in the 
exploratory MANOVA including both relevant internalizing symptoms and cognitive 
functioning, the ADHD + SCT subjects were found to have greater difficulty with affect 
regulation than the ADHD-only subjects. This change in significance occurred despite the 
difference in mean scores between these two groups remaining constant between the two 
analyses.  
These findings imply that the SCT symptomatology may be related to challenges 
with depression, anxiety, and affect regulation in adults with ADHD. One possible 
explanation for this relationship is the similarity between the symptoms investigated. 
Theories attempting to explain the close relationship between anxiety, depression, and 
SCT posits these constructs share several core features common to internalizing 
disorders, such as apathy, rumination, daydreaming, inactivity, and decreased effort 
(Smith & Langberg, 2017).  
There are also similarities in the symptoms investigated by the measures used to 
operationalize SCT and depression. Both the SCT scale of the BAARS-IV and the BDI-II 
have items pertaining to loss of energy, fatigue, and difficulty concentrating (Barkley, 
2011a; Beck et al., 1996). A number of studies have demonstrated that SCT is a distinct 
syndrome from ADHD and internalizing disorders (Barkley, 2011a, 2012; Becker et al., 
2016; Garner et al., 2010; Wåhlstedt & Bohlin, 2010). The findings of this study lend 
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credence to the theory that the strong relationship between internalizing symptoms and 
SCT may be attributable to a common etiology, rather than a simple overlap in nosology. 
Neuroticism, as measured by the NEO-PI-R, was not found to be meaningfully 
related to diagnostic group membership or SCT symptomatology in the analyses 
conducted. This contrasts with previous studies that have found relationships between 
neuroticism, ADHD symptomatology, and SCT (Becker et al., 2018; Serine, 2016). 
Neuroticism has been found to be a common element among internalizing disorders, and 
has demonstrated significant correlations with internalizing symptoms (Griffith et al., 
2010). The univariate ANOVAs that found the nonsignificant effects of diagnostic group 
on neuroticism were very underpowered in both the planned MANOVA (α = .01, 1-β = 
.068) and exploratory MANOVA (α = .05, 1-β = .225). This decreased the likelihood that 
a true effect could be detected, if one was present.  
Differences in Cognitive Functioning Between Diagnostic Groups 
The current study explored the differences in cognitive functioning, utilizing 
measures of cognitive processing speed, auditory working memory, and deficits in 
executive functioning. Interestingly, subjects’ scores on the measures of cognitive 
functioning used in the MANOVA were not correlated with one another, so the analysis 
could not be interpreted. Contrary to the second hypothesis, neither subjects’ auditory 
working memory nor their cognitive processing speed abilities were meaningfully related 
to SCT symptomatology or diagnostic group across these analyses. This contrasts with 
previous research that has found low to moderate effect sizes when examining the 
relationship between subtests measuring working memory and processing speed from the 
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WAIS and ADHD or SCT symptomatology (Hervy et al., 2004; Jacobson et al., 2018; 
Wechsler, 2008). 
The lack of significant correlations may be attributable to the variety in constructs 
operationalized by the measures. Although processing speed, auditory working memory, 
and executive functioning are all meaningful pieces of an individual’s cognitive abilities, 
they may be too disparate from one another to be conceptualized as parts of a similar 
group of cognitive functions. Similar issues have arisen in past research that used loosely 
related aspects of cognitive functioning to create a new composite score for use in 
statistical analysis (Bauermeister et al., 2012).  
Slow or “sluggish” processing speed is considered a key characteristic feature of 
SCT (Becker & Barkley, 2018). The lack of significant relationships between subjects’ 
SCT symptoms and their performance on the Coding task of the WAIS-IV in this study 
was unexpected. Previous research has found limited utility in using neuropsychological 
measures of processing speed or working memory in diagnosing ADHD and SCT. 
Diffuse deficits across multiple neuropsychological and cognitive domains in this 
population may lead to inconsistent findings across studies examining this population 
(Barkley, 2019; Hervey et al., 2004; Mapou, 2019). The false negative rate of most 
neuropsychological measures is too high to be used as diagnostic measures for ADHD 
(Barkley, 2019; Matier-Sharma et al., 1995; Ramsay, 2015). Perhaps these limitations are 
also true for using neuropsychological measures to diagnose and measure the symptoms 
of SCT.   
Recent research found preliminary support for the idea that SCT symptoms in 
adolescents are more clearly associated with measures of processing speed as the motor 
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demands of the measure increase. Measures of processing speed that have high motor 
demands, such as the grooved pegboard test, evince stronger relationships with SCT, 
whereas test with moderate to low motor demands, such as the Coding task, exhibit 
weaker and inconsistent relationships with SCT (Becker et al., 2020). Another study 
found many commonly used measures of processing speed also require an individual to 
tap into executive functioning abilities such as goal maintenance or decision making. 
These unintentional demands from the measure cause executive functioning abilities to 
contribute to the subject’s performance on the measure. These additional test demands 
could potentially taint the operationalization of processing speed in research utilizing 
these measures and may have resulted in an over estimation of processing speed’s 
relationships with other constructs in prior research (Cepeda et al.,, 2013).  
Use of these measures may have contributed to the variation in significance and 
effect size in research examining SCT, ADHD, and processing speed, because the 
measures of processing speed utilized may be tapping into an unrelated constructs such as 
motor control, or constructs highly related to ADHD and SCT symptoms such as 
executive functioning. Future research would benefit from identification and utilization 
of measures that are relatively pure measures of processing speed. These would 
demonstrate good convergent validity with other measures of processing speed as well as 
discriminant validity from adjacent cognitive abilities like executive functioning. 
Clinically, neuropsychological measures provide valuable information on 
cognitive deficits, and are useful for identifying targets for intervention and treatment 
planning, but may not be ideal for examining the deficits in individuals with ADHD or 
SCT in research settings (Mapou, 2019). Clinicians and researchers advocate for more 
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ecologically valid tools with better predictive power for identifying the difficulties in 
cognitive functioning those with ADHD and SCT face. These include clinical interviews 
or self-report measures of executive functioning, such as the BDEFS utilized in this study 
(Barkley 2011b, 2019; Barkley & Fischer, 2011; Pettersson et al., 2018). 
Executive dysfunction, operationalized as the BDEFS Summary score, was 
strongly associated with SCT symptomatology but varied between diagnostic groups. In 
fact, both the exploratory ANOVA and exploratory MANOVA found that BDEFS 
Summary scores significantly varied between diagnostic groups. Specifically, the 
ADHD + SCT group exhibited greater deficits in executive functioning than the ADHD + 
subclinical SCT and ADHD-only groups. Executive functioning did not significantly 
differ between the ADHD + subclinical SCT and ADHD-only groups. Although not part 
of the planned analyses testing the hypotheses for this study, these findings lend some 
support to the second hypothesis, that the ADHD + SCT group would exhibit 
significantly more impaired cognitive functioning than other diagnostic groups. These 
results are consistent with prior research findings indicating differing patterns of 
executive functioning in adults with ADHD and SCT (Barkley, 2011b, 2012; Willcutt et 
al., 2005).  
Predicting SCT Symptoms Based on Internalizing Symptoms, Cognitive 
Functioning, and ADHD Symptomatology  
 The regression analysis examined which co-occurring internalizing symptoms and 
aspects of cognitive functioning were the most predictive of SCT in this sample. 
Depression and executive functioning emerged as the only significant predictors of SCT 
symptoms of the eight constructs investigated. Neither of the ADHD symptom scales 
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from the CAARS measure was correlated with SCT symptomatology in this analysis. 
This is partially consistent with the third hypothesis, that anxiety and deficits in executive 
functioning would predict subjects’ levels of SCT after accounting for ADHD 
symptomatology.  
The lack of a correlation between ADHD and SCT symptoms was 
unexpectedbecause SCT symptoms, operationalized as the BAARS-IV SCT subscale, 
have been found to significantly correlate with inattentive symptoms, operationalized as 
the CAARS, in prior studies. Moreover, SCT shares as much as 50% of its variance with 
inattentive symptoms and up to 25% of its variance with hyperactive/impulsive 
symptoms (Becker & Barkley, 2018; Garner et al., 2010; Leikauf & Solanto, 2017; 
Wåhlstedt, & Bohlin, 2010). ADHD and SCT commonly co occur in the general 
population, and individuals diagnosed with ADHD + SCT made up over half of the 
subjects in this study. However, this surprising finding is consistent with prior research 
conducted to validate SCT as a separate issue from ADHD. These studies demonstrated 
the symptoms of SCT align with a different factor than the symptoms of ADHD 
(Barkley, 2011a; Bauermeister et al., 2012; Becker, Marshall, & McBurnett, 2014; 
Neeper & Lahey, 1986).  
Anxiety was hypothesized to be the internalizing symptom that would have the 
most influence on SCT, due to similarities between rumination and avoidance in anxiety 
disorders and the daydreaming and low initiation aspects of SCT (Jacobson et al., 2018). 
However depressive symptoms, operationalized as subjects’ scores on the BDI-II, 
emerged as the only internalizing symptom that was a significant contributor to a 
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regression model predicting SCT symptom levels (standardized beta coefficient = .215, 
p = .013).  
This finding is consistent with a previous study that explored the utility of adding 
SCT as a predictor variable to multiple regression models attempting to predict 
depression and anxiety. Adding SCT to the model reduced the predictive utility of 
measures of ADHD symptoms and mental health treatment usage to nonsignificance, and 
notably increased the amount of variance explained by the models (Becker, Langberg, et 
al., 2014). These findings, combined with the present finding that depressive symptoms 
significantly predict SCT, supports the idea that the symptoms of depression and SCT 
have a reciprocal relationship, independent of their associations with ADHD 
symptomatology. These findings also imply that the feelings of apathy, lethargy, and 
psychomotor retardation common to depression and SCT are not merely superficially 
similar, but stem from a common underlying problem or factor.  
Executive functioning emerged as the strongest predictor of SCT symptoms in the 
regression model (standardized beta coefficient = .403, p < .001). This was consistent 
with the third hypothesis’ prediction that executive functioning would predict subjects’ 
levels of SCT in the analysis. Several studies have established executive functioning is a 
better predictor of SCT symptoms than ADHD symptoms or internalizing symptoms, 
even when controlling for the relationship between executive functioning and other 
predictor variables (Flannery et al., 2016; Jarrett et al., 2017; Leikauf & Solanto, 2017).  
For clinical practice, these results indicate the need for pretreatment screening for 
SCT and executive dysfunction in individuals with major depressive disorder and other 
mood disorders. Individuals with depression often experience symptoms that cause 
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impairment in their ability to function such as anhedonia, fatigue, difficulty thinking or 
concentrating, insomnia/hypersomnia, and inappropriate feelings of worthlessness or 
guilt. SCT may be contributing to or maintaining these symptoms, leading to greater 
impairment or interference with treatment efforts to manage depression or other mood 
symptoms. Individuals experiencing depression and SCT may benefit from the 
introduction of interventions that are typically used with individuals diagnosed with 
ADHD. These interventions could enhance motivation, manage fatigue, and interrupt 
rumination and daydreaming that occur in both SCT and depression.  
The ADHD + SCT group exhibited greater levels of depression, anxiety, emotion 
dysregulation, and executive dysfunction than the ADHD + subclinical SCT or ADHD-
only groups in the exploratory analyses. Measures of depression and executive 
dysfunction were found to be significant predictors of subjects’ SCT symptomatology, 
whereas ADHD symptomatology was unrelated to SCT in this sample. This and other 
studies have demonstrated that ADHD and SCT are distinct psychological constructs, 
SCT is associated with internalizing symptomatology, and depression and executive 
functioning play a stronger role in the presence of SCT than ADHD (Bauermeister et al., 
2012; Becker, Langberg, et al., 2014; Carlson & Mann, 2002; Flannery et al.,, 2016; 
Jarrett et al., 2017; Kamradt et al., 2018; Leikauf & Solanto, 2017).  
Limitations  
 Limitations of the data set. This study utilized an existing data set. As a result, 
there were some artifacts that limited the analyses conducted and the generalizability of 
conclusions drawn from them. Across the analyses in this study, there were unequal 
sample sizes, violations of the assumptions of covariance, violation of the assumptions of 
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equal variance, as well as skewed and leptokurtic data for some measures. These 
limitations of the data may have impacted Type 1 error levels of the analyses conducted 
and limited the generalizability of the findings.  
The data was gathered from new clients during intake at a university-based, adult 
ADHD outpatient specialty clinic in a large urban area. Individuals with clinical levels of 
both ADHD and SCT symptomatology are overrepresented in the sample, whereas 
individuals with SCT only are underrepresented, leading to unequal group sizes. Subjects 
in the SCT-only group had one significant between-groups difference across all of the 
analyses. It is possible that the very small sample size of SCT-only subjects was 
insufficient to provide enough power to detect meaningful differences with other groups.  
The proportion of subjects in this sample with clinical levels of SCT only was 
comparable to that found in previous research. The prevalence of SCT in the adult 
population is difficult to determine because of the close relationship between ADHD, 
SCT, and other mental health symptomatology, as well as the status of SCT as a newly 
identified and less well-defined mental health construct (Barkley, 2012; Becker & 
Barkley, 2018; Lunsford-Avery & Mitchell, 2018). Barkley’s (2012) research validating 
the BAARS-IV SCT subscale found that 5.8% of sampled adults endorsed five or more 
symptoms on the SCT subscale, indicating clinical levels of SCT. Furthermore, of the 
sample of 1,249 participants in Barkley’s study, 72 (5.76%) met criteria for SCT, with 33 
(2.64%) meeting criteria for SCT but not ADHD (Barkley, 2012). Of the participants in 
the present study, only 7 (4.9%) adults met criteria for SCT only. It is possible the 
number of subjects with SCT only in this sample is representative of a low prevalence of 
clinical levels of SCT without ADHD in the adult population.  
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The imbalance in group sizes and negligible number of SCT-only subjects may 
also be attributable to sampling bias for the clinic where the data were collected. New 
clients who present for an intake at the outpatient specialty treatment clinic are likely 
pursuing treatment for ADHD symptoms and co-occurring disorders. ADHD and SCT 
frequently co-occur. Although seeking treatment for SCT symptoms at an ADHD 
specialty clinic seems natural for those well versed in neurodevelopmental disorders or 
executive dysfunction, a layperson who is experiencing only the symptoms of SCT may 
not identify feelings of apathy, mental fogginess, and slow processing speed as a 
developmental disorder related to ADHD. This would reduce the likelihood that they 
would present for treatment at an adult ADHD outpatient specialty clinic and could 
potentially lead to sampling bias for individuals with higher levels of ADHD symptoms 
and bias against those with SCT only.  
One critique secondary data analysis research is that the conclusions drawn from 
these studies are limited to the samples from which they are drawn. These findings may 
not be generalizable to larger populations or may be valid only for groups adequately 
represented in the sample (Barkley, 2019). Of the 143 subjects in this study, 93 identified 
as male and 111 were Caucasian. Ages and education level were both normally 
distributed. Subjects’ age approached positive skewness (.91), indicating many subjects 
were on the younger side of the age distribution. Mean education level was 15.74 years, 
with a mode of 16. Only 16 of the 143 subjects reported having a high school education 
or less.  
The clinic at which the data were collected is within close proximity to several 
large colleges and universities. Although information about subjects’ student status was 
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not retained for the data used in this analysis, the ages and education levels in the sample 
may reflect a sampling bias for individuals who either attend or work for these academic 
institutions. As a result, the findings of this study may better reflect symptomatology in 
young Caucasian men with clinical levels of ADHD and SCT who have completed or are 
currently enrolled in a college degree program, rather than the population of adults with 
ADHD.  
Previous research on malingering and ADHD assessment has shown that college 
students may over report their ADHD symptoms for secondary gain (Sollman et al., 
2010). The use of self-report measures may have also led to underreporting of mental 
health symptoms. Young adults with ADHD tend to underreport symptoms of ADHD 
and other mental health disorders, due to a lack of insight about their symptoms (Barkley 
et al., 2008).  
Although many of the subjects had an initial diagnosis of ADHD from the intake 
process, some may have received treatment for ADHD, internalizing disorders, or another 
mental health issue prior to or concurrently with the evaluation. Subjects who have 
benefitted from this treatment may exhibit fewer symptoms of ADHD, lower levels of 
internalizing symptoms, or less impairment in executive functioning than those who have 
never received treatment (Kessler et al., 2006). The data set did not contain information 
on subjects’ treatment history, so there is no way to control for potential confounds.  
Another limitation of this study lies in its use of the Coding task and the Digit 
Span task to operationalize cognitive functioning. Although these subtests from the 
WAIS-IV have established validity as measures of processing speed and auditory 
working memory, the operationalization of these measures could have been improved if 
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the subjects had been administered all of the subtests from the standard WAIS-IV battery. 
This would have allowed the study to utilize the PSI and working memory index (WMI). 
The WMI and PSI are each calculated from three different WAIS-IV subtests, whereas 
only two relevant subtests were administered as part of the diagnostic battery at the 
university-based, adult ADHD outpatient specialty clinic. Therefore, this study was only 
able to utilize only one subtest from the WMI and one from the PSI as opposed to three 
from each.  
Limitations of the analyses. In the MANOVA testing hypothesis 1 and in the 
exploratory MANOVA, Levene’s test indicated the variance was unequal between the 
four diagnostic groups on their BDI-II, PSWQ, Digit Span, and BDEFS Summary scores. 
Because the size of the diagnostic groups was unequal and there was heterogeneity in the 
variance of the groups, the accuracy of the F ratio may have been impacted, leading to 
altered Type 1 error rates. Robust post hoc ANOVAs using the Brown-Forsythe statistic 
caused the between groups differences on the BDI-II and PSWQ to decrease from 
statistical significance to approaching significance only.  
Follow-up discriminant analyses to the first MANOVA utilizing ANOVAs were 
slightly under the desired power level of .80 for subjects’ scores on the BDI-II (1-β = 
.751), PSWQ (1-β = .670), and BADDS-Affect (1-β =.715). NEO-neuroticism was very 
underpowered in this analysis (1-β =.068). Discriminant analyses to the exploratory 
MANOVA utilizing ANOVAs were underpowered for the Digit Span task (1-β = .138) 
and again for NEO-neuroticism, (1-β = .225). These underpowered analyses may have 
led to increased Type II error rates and could have contributed to the nonsignificant 
findings for these specific analyses (Field, 2013). 
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Several variables used in the analyses demonstrated troublesome levels of skew 
and kurtosis. Subjects’ SCT Percentile Ranks were found to be negatively skewed 
(-2.317) and leptokurtic (6.939). BDEFS Summary scores were positively skewed (3.128) 
and leptokurtic (12.022). CAARS Inattentive symptom scores were negligibly negatively 
skewed (-2.054) and leptokurtic (6.847). Although skewed and leptokurtic scores on 
measures of SCT, ADHD, and executive dysfunction would be expected in a clinical 
sample of individuals diagnosed with ADHD and SCT, these abnormal distributions 
violated the assumption of normalcy of the data.  
Due to unequal sample sizes, groups differing along more than one variate, and 
violations of normalcy of the data, Pillai’s trace was used as the significance statistic for 
the MANOVAs because it is more robust than the other statistics to violations of model 
assumptions (Olson, 1974; Field, 2013). The Games Howell statistic and Brown-Forsythe 
statistic were used for post hoc comparisons of groups because they are more robust 
statistics when the assumption of homogeneity of covariance is violated. Although steps 
were taken to accommodate violations of normalcy in these analyses, findings should be 
interpreted with caution. These test statistics are robust to violations of test and data 
assumptions, but not immune to error or bias.  
Future Directions  
More research is needed to examine how SCT relates to ADHD in various 
populations of adults. Most of the studies reviewed were conducted on schoolchildren or 
undergraduate students. Few studies have examined measures of SCT in adult 
populations or in clinical settings (Lunsford-Avery, 2018). This study was also limited by 
an overrepresentation of individuals with 16 years or more of education, Caucasians, and 
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males. Future research into SCT should utilize both clinical and nonclinical samples from 
a variety of adult populations, including samples from community-based mental health 
clinics to access more diversity in participant demographics. Presentations of SCT in 
undersampled populations, such as ethnic and cultural minority groups or individuals 
with learning disabilities, should be explored to determine if SCT is overrepresented or 
underrepresented in these groups.  
The use of exisiting data for these analyses resulted in unequal sizes in diagnostic 
groups and a dearth of subjects with SCT only. Future studies would benefit from 
recruiting and individuals with the express purpose of maintaining approximately equal 
diagnostic group sizes. This would potentially reduce error caused by unequal groups and 
would allow for a clearer investigation of the profiles of individuals with SCT only.  
 A uniformly agreed-upon set of criteria to diagnose SCT does not currently exist. 
By better understanding the etiology of SCT as well as the symptoms and disorders that 
commonly co-occur with SCT, it would be possible to formally delineate diagnostic 
criteria or identify key symptoms that can be used to diagnose and identify SCT. 
 Barkley found that SCT symptoms contributed the majority of the variance to 
different subscales of the BDEFS. Future research could expand upon this by examining 
the differences among diagnostic groups across the five subscales of the BDEFS or other 
valid measures of discrete executive functions. The close relationship of SCT with 
depression suggests a common underlying factor. Diagnostic groups of subjects with 
varying levels of ADHD and current major depressive disorder could be compared with 
ADHD-only subjects to explore the differences in SCT symptomatology. If SCT and 
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depression share a common factor, such as internalization, then the groups with higher 
levels of depression would have higher scores on an SCT measure.  
 In sum, these findings contribute to the research on the etiology and co-occurring 
mental health symptoms in adults with ADHD and SCT. This study’s findings indicate 
internalizing symptoms and executive dysfunction are greater in those with clinically 
significant levels of ADHD and SCT. SCT, depression, and executive dysfunction had 
closer relationships to one another than ADHD symptoms in a sample of adults 
diagnosed with ADHD. Perhaps SCT symptomatology reflects a place in psychological 
pathology where “the boundaries between disorders are more porous than originally 
perceived” (American Psychiatric Association, 2013, p. 6).  
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Appendix 


















ADHD + SCT ADHD + 
subclinical SCT 
2.29 2.247 .567 -3.07 7.65 
ADHD-only 3.51 2.765 .419 -3.18 10.21 
ADHD + 
subclinical SCT 
ADHD + SCT -2.29 2.247 .567 -7.65 3.07 
ADHD-only 1.22 2.901 .907 -5.79 8.24 
ADHD-only ADHD + SCT -3.51 2.765 .419 -10.21 3.18 
ADHD + 
subclinical SCT 
-1.22 2.901 ..907 -8.24 5.79 
Beck Depression 
Inventory-II 
ADHD + SCT ADHD + 
subclinical SCT 
4.24 1.938 .079 -.38 8.86 
ADHD-only 7.96*** 1.942 .000 3.30 12.61 
ADHD + 
subclinical SCT 
ADHD + SCT -4.24 1.938 .079 -8.86 .38 
ADHD-only 3.72 2.051 .175 -1.22 8.65 
ADHD-only ADHD + SCT -7.96*** 1.942 .000 -12.61 -3.30 
ADHD + 
subclinical SCT 
-3.72 2.051 .175 -8.65 1.22 
 














Penn State Worry 
Questionnaire 
ADHD + SCT ADHD + 
subclinical SCT 
7.89* 2.915 .023 .91 14.87 
ADHD-only 9.48* 3.607 .032 .70 18.27 
ADHD + 
subclinical SCT 
ADHD + SCT -7.89* 2.915 .023 -14.87 -.91 
ADHD-only 1.59 4.010 .917 -8.09 11.28 
ADHD-only ADHD + SCT -9.48* 3.607 .032 -18.27 -.70 
ADHD + 
subclinical SCT 
-1.59 4.010 .917 -11.28 8.09 
Brown ADD Scales-
Affect, T Score 
ADHD + SCT ADHD + 
subclinical SCT 
8.11** 2.480 .005 2.18 14.04 
ADHD-only 6.92* 2.591 .027 .66 13.18 
ADHD + 
subclinical SCT 
ADHD + SCT -8.11** 2.480 .005 -14.04 -2.18 
ADHD-only -1.19 2.930 .914 -8.24 5.86 
ADHD-only ADHD + SCT -6.92* 2.591 .027 -13.18 -.66 
ADHD + 
subclinical SCT 
1.19 2.930 .914 -5.86 8.24 
 
  















WAIS-IV Digit Span 
task, Scaled 
Score 
ADHD + SCT ADHD + 
subclinical SCT 
.49 .566 .659 -.86 1.85 
ADHD-only .50 .522 .609 -.75 1.75 
ADHD + 
subclinical SCT 
ADHD + SCT -.49 .566 .659 -1.85 .86 
ADHD-only .00 .587 1.000 -1.41 1.41 
ADHD-only ADHD + SCT -.50 .522 .609 -1.75 .75 
ADHD + 
subclinical SCT 
.00 .587 1.000 -1.41 1.41 
Barkley Deficits in 
Executive 
Functioning 
Scale: Self Report 
- Total EF 
Summary score 
ADHD + SCT ADHD + 
subclinical SCT 
5.53* 2.126 .034 .36 10.70 
ADHD-only 7.42** 1.831 .001 2.91 11.93 
ADHD + 
subclinical SCT 
ADHD + SCT -5.53* 2.126 .034 -10.70 -.36 
ADHD-only 1.90 2.686 .761 -4.56 8.35 
ADHD-only ADHD + SCT -7.42* 1.831 .001 -11.93 -2.91 
ADHD + 
subclinical SCT 
-1.90 2.686 .761 -8.35 4.56 
 
